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Abstract
Fibroblast growth factor receptor plays a major role in several biological processes. Without FGFR, a
human cannot live. FGFR is involved in cell differentiation and wound healing. Of course, if FGFR
signaling becomes unregulated, it causes severe distress in the body. Several cancers are contributed to
high signaling levels, as well as developmental conditions like rickets and Kallmann’s syndrome. FGFR
is thought to undergo an auto-inhibition (or self-regulatory) process in order to try to facilitate regulation.
The exact method of this inhibition is currently unknown, but is proposed to involve the unstructured acid
box region of FGFR. We developed a simple model system in order to further investigate current models
of inhibition that FGFR may undergo. By using our model system, which contains two 15-mer
homopolypeptides of polyE and polyK that mimic the acid box region and its binding site respectively,
we were able to use a combination of ITC, CD, NMR, and FRET to show that one model from the
literature contains flaws. We are able to characterize the binding of our polypeptide system under varying
ionic conditions and pH. This model system also provides a platform to better understand general
principles of charge-charge interactions in proteins, which are often characterized by FRET. One of the
important findings from this study is that 15-mers of polyE and polyK bind in a parallel arrangement. One
of the hurdles in applying FRET to such systems is determining the role that the attached FRET dyes play
in the charge-charge interactions. Our model system allowed us to use the preference of the charged
polypeptides to bind in a parallel arrangement to determine the size, charge and structural effects of the
attached FRET dyes on how peptides bind under electrostatic interaction conditions and to quantify how
the attached fluorescent dyes are quenched by both the charged amino acids as well as by the FRET
acceptor.
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I. Introduction
1.1 Protein Makeup and Structure
All biological lifeforms consist of proteins1. Even though the number, size, and shape of
proteins are limitless, all are made up from the same 20 amino acids. Each amino acid has its
own characteristics which contribute to the protein’s structure and/or function. The various side
chains on the amino acids determine how the protein will fold based upon the charge and
hydrophobicity of the functional group of the amino acid2. Out of the 20 total amino acids, there
are 4 that have a charge at physical pH, 7.2. This small percentage of charged amino acids
represents the need to regulate the total charge of a protein. Too many charges would hinder a
protein from folding to a compact structure3, which many need to perform their function. The
overall structure of a protein determines its function and where in the cell the protein will be
located. Not all proteins fold the same way, with some proteins having a loose, flexible structure
while others are rigid. It has long been thought that the structure of a protein determined its
function4 until relativity recently, even though this is still true for most proteins. Most proteins
function by binding to other proteins or small molecules inside of the cell. This binding can
occur by a variety of means including, but not limited to, oppositely charged (electrostatic)
interactions, hydrogen bonding and hydrophobic forces. When a ligand binds to a protein, the
protein will often slightly change its structure to enable the ligand to bind more tightly or to
facilitate another ligand to bind5. Often, the structure of the ligand will match that of the protein
that it is designed to bind – the lock-and-key mechanism6. If binding occurs through opposite
charges (electrostatic interactions), the ligand and protein will have surface-charge
complementarity, which means that the protein will have a pocket of negatively charged amino
acids and the ligand will contain an area of positively charged amino acids, or vice versa.

1

1.2 Intrinsically Disordered Proteins
Many of the molecular targets for protein binding are not shape determined, as some
proteins are intrinsically disordered. This type of disorder can mean that the protein does not
have specific secondary structural elements such as alpha helices or beta sheets that often
contribute to protein shape. It can even mean that the protein has no shape whatsoever.
Intrinsically disordered proteins (IDP’s) make up roughly 33% of the known proteins today in
eukaryotic systems7. Though once thought to have no function8, several very important roles
have been found to be performed by IDP’s9. There is evidence for their participation in cell
signaling and transcription factors10, as well as having been connected to several important
diseases such as Alzheimer’s and cancer11. Intrinsically disordered proteins or peptides
generally contain a high number of charged amino acids12, and most of their function arises from
the polarity of charges of their amino acids as well as their sequence/density. There are different
binding/folding models for IDP’s that are thought to drive the binding process. One such model
is the “fly-casting” mechanism. This particular mechanism uses the fact that the IDP is initially
unfolded and elongated, containing a high degree of entropy. With the high density of charged
residues, the protein is able to use long-range electrostatic forces to “feel” around for its binding
partner. Once bound weakly through these electrostatic interactions, the protein can begin to
form a more specific structure and bind more tightly to its partner13. This model accounts for the
observation of fast binding kinetics and takes into account the extreme flexibility of unfolded
proteins14. A second model recognizes that some IDP’s never fold, even after binding. Termed
the “fuzzy complex” mechanism, the IDP stays unfolded after binding to an ordered protein15. A
typical example of an IDP binding to a structured protein is the p53 protein binding to MDM2.
p53 is a mostly disordered protein that is involved in tumor suppression. MDM2 is a globular
2

protein that negatively regulates p53. p53 binds to MDM2 through one of the disordered regions
on p53, mainly through hydrophobic and aromatic residues. Once bound, this disordered region
then adopts a helical coil structure16. This protein, like many others, was initially thought to not
have a function for the disordered region, since there are ordered regions that were known to be
involved in DNA binding. Some proteins bind through charge-charge interactions only though.
An example of this includes the Sac10b family that binds to DNA17. This family is made up of
small proteins that bind to DNA with no sequence specificity. These proteins protect the DNA
from digestion by Dnase I. This family of proteins is highly conserved and contains 3 pairs of
positively charged residues that bind to DNA. When these amino acids are changed to uncharged
residues, the protein cannot bind to DNA.
1.3 Electrostatic Interactions
One of the primary binding mechanisms of proteins is through charge-charge interactions
from electrostatic forces. Coulomb’s law tells us how strong electrostatic interactions are based
upon distance by the formula: F = k q1 q2 / r2 where F is the force, q 1and 2 are electric charges, r
is distance, and k is proportionality constant. This information is very helpful when determining
how neighboring charges affect each other when a protein is folding or when a ligand is trying to
bind since like charges repel each other while opposite charges attract. A large percentage of
proteins have charged amino acids in their binding pockets that facilitate the binding of their
partner. The lock-and-key binding model18 is the most common binding model for folded
proteins that have complementary shapes and charges. However, when there is no structural
complementarity between partners, the charges themselves must be the leading factor for getting
proteins to bind to ligands or other molecules. The electrostatic interactions between the protein
and ligand are the only aspect that can contribute to binding other than hydrogen bonds which
are substantially weaker. Coulomb’s law tells us that opposite charges attract each other, and at
3

what distances these charges can be recognized by other molecules but not much information has
been acquired about how the surface-charge complementarity19 and the binding affinity of
protein targets relate. It is also unknown how the peptides with highly charged residues orient
themselves and how do the proteins find their partner and not just bind to everything charged
they come across.
1.4 Fibroblast Growth Factor Receptor
One particular interesting example for a protein with a functionally-important, as well as
potentially being cancer-related, intrinsically disordered region is the fibroblast growth factor
receptor (FGFR). FGFR’s are known to play a role in wound healing, cell growth, and new blood
vessel growth (angiogenesis) among many other biological processes20. On the other hand,
overexpression of FGFR’s can lead to cancer with the most common types being colorectal21, 22,
gastric23, 24, bladder25, 26, and pancreatic cancers27, 28. Mutations of the FGFR protein can also
cause cancer by changing the activation of pathways that stimulate tumor growth29. There are 4
known FGFRs, each consisting of 3 immunoglobulin-like domains (D1, D2 and D3), an acid box
(AB) region linking D1 and D2, a transmembrane domain that follows D3, followed by a
cytoplasmic tyrosine kinase domain30. The AB region is an intrinsically disordered region, and
is thus very flexible. It gets its name from the high percentage of acidic residues found there;
nearly 50% of the amino acids are acidic, and are negatively charged at physiological pH31. The
amino acid sequence of the acid box of FGFR2 is shown in figure 1.1.

VTDAISSGDDEDDTDGA
Figure 1.1. The amino acid sequence of the FGFR2 acid box. The charged residues are
highlighted in red. The high percentage of charged residues makes this protein region one of
interest. The charged residues are potentially involved in binding to a ligand binding site on a
domain in the protein.
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The two main binding partners for FGFR are FGF and heparin; their binding sites are on
the D2 domain with a small portion of the FGF interacting with the D3 domain. There are 2
exons that code for the last half of the D3 domain in most FGFR’s that can cause two different
isoforms of the receptor32. One variant is expressed in epithelial tissue while the other is found in
mesenchymal tissue33. This alternative splicing changes the specificity of the receptor to
different FGF proteins that have been identified34. Most published structures of FGFRs consist
only of the D2 and D3 regions in a dimeric complex with its FGF and heparin partners (figure
1.2). Currently there are no crystal structures for FGFR that have been determined in the
absence of ligand35. Not having an uncomplexed structure available makes it very difficult to get
mechanistic information about the protein.

Figure 1.2. FGFR/heparin complex. A) View from the side of the complex. FGFR2 domains
D2 and D3 are cyan and magenta, respectively, and FGF1 is green. The heparin molecule is
shown in red. B) View from the top down36.
1.5 Fibroblast Growth Factors
Fibroblast growth factors (FGF’s) were the first known angiogenic factors37, 38. There are
22 known human FGF’s 39, with these proteins being found in both vertebrates and invertebrates.
The FGF genes are widespread throughout the human genome and are located on several
5

different chromosomes. FGFs can be divided into subgroups with each subgroup having a high
percentage of sequence similarity and developmental properties. The range of molecular weights
for human FGFs is between 17 and 34kDa. There is a highly conserved core region that contains
28 homologous amino acids, of which 6 are identical20. Ten of the core amino acids interact
directly with FGFR40. The mammalian FGFs are expressed in almost all tissues but in different
patterns and at different times41. FGFs are glycoproteins that are found in the extracellular matrix
and on the cell surface. In order for them to be used in signaling, they first have to be released
into the extracellular matrix to be exposed to the cell surface, where they bind to heparin and the
membrane-bound receptor 42. Once the FGF is bound to the receptor, dimerization occurs. At this
point it is thought that heparin sulfate glycosaminoglycan binds to a specific site on the dimer,
although there is still debate on exactly when heparin binds. Some researchers propose that the
heparin binds to FGF before it binds to the receptor, thereby stabilizing the protein against
degradation 43. In any case, the formation of the dimer causes a conformational change that
activates the tyrosine kinase domain which results in it becoming phosphorylated. This
phosphorylated residue acts as a docking area when the FGFR interacts with other proteins,
which starts a signaling cascade consisting of multiple pathways. FGF receptors are also
involved in negative feedback regulations, though not much about the mechanism is known,
except that the receptor is degraded. Fibroblast growth factors undergo auto-regulation to
balance cell growth and death to maintain a healthy state. When the regulation breaks down,
FGF’s may become involved in many different diseases such as cancer42, 44, rickets45, 46, and
Kallmann syndrome39. Overexpression of some FGFR’s has been shown to produce tumors but it
is not clear whether it is because the higher amounts of FGF receptor binds more ligands to result
in higher signaling or if the tumors respond directly to higher amounts of FGF 42.

6

1.6 Fibroblast Growth Factor Receptor Signaling and Regulation
FGFR is involved in several different signaling pathways including RAS/MAPK and PI-3
kinase/Akt (figure 1.3). The signaling for this receptor starts when FGF and heparin or heparin
sulfate bind to the extracellular domains, D2 and D3, on FGFR causing receptor dimerization
and activation that causes the tyrosine kinase domain to auto-phosphorylate. Signaling proteins
such as STAT1, Gab1, and FRS2α are then phosphorylated so they can begin their roles in cell
differentiation, cell survival, and cell proliferation20. Regulation for FGFR involves pericellular
matrix heparin sulfate. This small molecule controls the FGFR signaling on many levels47 and
when it’s not available, the complex cannot be activated. Regulation can also come from the
different isoforms of the receptor. Natural splicing can change the D3 domain but it may also
remove the first domain (D1) and AB region. Both of these changes can cause the binding
affinity of FGF for the receptor to change by either increasing or decreasing the affinity of the
FGF for the receptor. For example, when the D1 and AB regions are removed from the receptor,
binding affinity increases between FGFR and FGF but in some isoforms where the D3 domain is
changed, the binding affinity of FGF1 to FGFR is greatly reduced48. FGFR is also thought to
undergo self-regulation by auto inhibition49. There are two competing theories surrounding the
auto inhibition or self-regulation of FGFR. In both cases, inhibition results in a reduction in the
receptors’ affinity for FGF48. One method proposes that FGFR undergoes auto inhibition by the
flexible acid box region swinging down and binding to the heparin binding site on the D2
domain (figure 1.4 A) 49-51. The rationale for this hypothesis is that the acid box region is highly
negatively charged while the heparin binding site in D2 is highly positively charged. Kalinina et
al have recently supported this hypothesis using NMR to determine which residues are perturbed
when the AB region of the protein is deleted versus when it is present51. Olsen et al. have shown
using Surface Plasmon Resonance that the presence of the D1 domain decreases the binding
7

affinity of heparin to an FGFR49, which was subsequently reproduced and extended by Kalinina
et al51. The competing hypothesis suggests that the acid box region binds to FGF instead of
FGFR, thereby blocking the FGF from binding to the FGFR’s D2 domain (figure 1.4 B)52.

Figure 1.3. Signaling pathway for FGF. Four of the pathways that are set in motion by the
phosphorylation of FGFR53. The yellow box represents the inside of the cell. The top left part of
the figure shows FGFR bound to heparin sulfate, FGF, as well as 3 signaling proteins: FRS2,
JAK, and PLCγ. The various pathways are shown that occur once the dimerization and
phosphorylation of FGFR occur.
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A

B

Figure 1.4. Proposed model for auto inhibition of FGFR.A) The acid box binds to the heparin
binding site of the D2 domain. B) FGF binds to the acid box and blocks the FGF binding site on
the D2 domain. Modified51, 52.
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1.7 Charged Homopolypeptides as a Model for Charge Complementarity
Homopolypeptides are constructed of a single type of amino acid repeated any number of
times. Homopolypeptides were used in the late 1960’s and 1970’s to study the stability of side
chain conformations,54-56 often by analyzing the Raman spectroscopic peaks caused by secondary
structure formation 57, 58. At that time, it was well known that long chains of glutamic acid would
form a random coil at pH 7 but could be forced into either an alpha helix by lowering the pH to
4, or a beta sheet by adding long chains of poly lysine. Poly lysine itself is a random coil at pH 7
and is alpha helical at pH 1159. Long chains of glutamic acid with long chains of lysine were
later used as films that helped to preserve the structure of DNA60, 61. The size of the polypeptide
chains used in previous studies have always been long (<100 amino acids). Recently shorter,
more relevant homopeptides have been the focus of study. For example, by using a peptide of 34
arginine residues, the effect of the net charge per residue on the globule to coil transition was
examined by replacing various arginine residues with other amino acids62. This study concluded
that a higher average charge per residue did increase the amount of coiled structure of peptides.
However, shorter, more biologically relevant versions of homopolypeptides – in terms of sizes
relevant to protein regions of interest, such as the acid box of FGFR described above – have not
been extensively studied. The binding between these unstructured, oppositely charged peptides
arises from electrostatic interactions. Homopolypeptides constructed of glutamic acids and lysine
are excellent subjects for binding interaction studies as they have charge complementarity and
are largely disordered at neutral pH55, they are also a good model for our possible acid
box/heparin binding site study since the major amino acid in the acid box is glutamic acid and
the possible binding site on the D2 domain consists of a positive region of residues. We will be
able to get an idea if the acid box/heparin binding site theory is practical based upon the amount
of binding in our model system.
10

1.8 Fluorescence and Quenching
Fluorescence is the emission of light from the excited state of a molecule (figure 1.5).
This emission occurs in usable timeframes and can be measured by simple machines. Quenching
occurs when the intensity of fluorescence is decreased or diminished altogether63. Quenching can
occur through wanted as well as unwanted means. Collisional quenching occurs after collisions
of the fluorophore with another molecule that causes the excited electron to return to its ground
state. Static quenching can occur if the fluorophore and another molecule form a stable
complex64.

Figure 1.5. Jablonski diagram for fluorescence. When an electron in the ground state is
excited, it moves into an excited singlet state (absorption). This electron can then return to the
ground state through different methods, one of them being fluorescence65.
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1.9 Fluorescence Resonance Energy Transfer
One use of fluorescence is in the technique of fluorescence resonance energy transfer
(FRET). In FRET, there is one fluorescent molecule (termed the donor) and another molecule
(termed the acceptor) that can accept the energy of the first molecule. FRET occurs by the donor
molecule being excited by an external source and becoming fluorescent. At distances unique to
the donor molecule but always less than 100 Å, the donor can transfer its energy to the acceptor.
This transfer of energy causes the donors’ fluorescent signal to decrease. If the acceptor
molecule is also fluorescent, then the acceptor will fluoresce once the energy has been
transferred (figure 1.6). It should be noted that the fluorescence of the donor is not transferred to
the acceptor, only the energy is transferred. The donors’ fluorescence will decrease when the
energy is transferred according to the amount of energy transferred. The energy transfer process
is dependent upon several factors including distance between dye molecules (figure 1.7) and the
overlap of the donor’s emission spectrum with the acceptors absorption spectrum (figure 1.8).
The amount of overlap of the two spectra will determine how much energy is transferred at a
given distance. The formula for the efficiency of energy transfer (E) is E = R06/ R06 +r6 where r
is the distance between the donor and acceptor molecules and R0 is the Forster distance. The
Forster distance is the distance at which the energy transfer is 50%, figure 1.7. This factor is
determined by the quantum yield (Q0) of the donor in the absence of the acceptor, the orientation
of the dipole (κ2) of the molecules, as well as the refractive index (η) of the medium in which the
molecules are in and the integral of the spectral overlap (J). The equation for Forster distance is
R06 = (9000 Q0 (ln10) κ2 J) / 128 π5 n4 NA where NA is Avogadro’s number. The Forster distance
is comparable to that of a biological macromolecules, since it is in the range of 20-100 Å.
Because of the strong distance dependence of FRET, this technique gives researchers the ability
to measure intra- and inter-molecular changes in proteins, DNA molecules, ion channels, and
12

many other biological molecules/systems that have structural or interactional changes. Some of
the uses for FRET include determination of structural characteristics of intrinsically disordered
proteins66, monitoring kinesin motor proteins67, and measuring the electrostatic repulsion
between the domains of calmodulin68. This is such a useful tool for analysis because it allows for
varying temperatures and ionic concentrations and, importantly, does not use large amounts of
sample. This technique is extremely sensitive and facilitates the use of very low concentrations
of sample by employing fluorescent dyes as labels on the amino acid residues of proteins or
peptides. By careful placement of the fluorescent dyes, the relative orientation of binding
partners can be elucidated.

Figure 1.6. FRET occurs through energy transfer. A) The donor (green) and acceptor (red)
molecules are close together so the donor’s energy is transferred to the acceptor. The donor is no
longer fluorescent but the acceptor is. B) The donor and acceptor are too far apart for energy
transfer to occur. The donor is fluorescent but the acceptor is not. Adapted from69.
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Figure 1.7. Distance dependence of energy transfer. The energy transfer efficiency varies for
every donor/acceptor pair but this chart shows how the distance and the Forster distance goes
together70.

Figure 1.8. Spectral overlap for donor and acceptor needed for FRET. On the left side we
can see that the spectra do not overlap and FRET does not occur as it does on the right side of the
figure71.
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1.10 Fluorescent Dyes
Fluorescent dyes come in a myriad of structures, sizes, and charges. There are several
properties of fluorescent dyes that are important when determining which ones to use, with the
most commonly considered ones being the wavelength of light that will be used and the quantum
yield of emission. The environment that the dye will be used in is also paramount. There are
some dyes that are designed to be used in vivo, namely near infrared fluorochromophores, while
others are strictly for in vitro like rhodamines. When measuring electrostatic interactions, the
charges of the dyes themselves should be taken into consideration, as well as the size of the dye,
especially if they will be placed close to the binding site. One property of fluorescent dyes that is
not normally but can be beneficial is fluorescence quenching. As we have seen, FRET is one
method of controlled quenching that we can use for measurements. Other types of quenching like
collisional and static quenching by environmental factors or other molecules in the solution are
not always welcome. When quenching occurs by a method other than the one being studied then
it is a hindrance. Most commercially available fluorescent dyes are stable and are thought to
resist minor environmental changes. Though fluorescent dyes have been used for many years, the
effects of the dyes on the measured values collected in FRET studies have not been studied
explicitly. We chose a system of two highly charged homopolypeptides that bind through
electrostatic interactions to measure the effects of the charges of the peptides on the fluorescence
of the dyes as well as the charges of the dyes on the binding of the peptides. By using multiple
dyes with various charges, we were able to determine the effects the peptide charges have on the
dyes, such as decrease in quantum yield, with no other possible contributions from factors
outside of our system like other proteins or molecules in solution.
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II. Thermodynamic and Structural Characterization of Interactions between Oppositely-Charged
Short-Chain Homopolypeptides

Ashley Howard, Nicole Webb, T.K.S. Kumar and Colin D. Heyes
2.1. Abstract
Interactions between charged amino acid residues have long been recognized as important in a
variety of intra- and inter- protein interactions. The prevalence of disordered regions in proteins
on the order of ~15 amino acids with high acidic or basic amino acid content has drawn recent
attention due to a general shifting in the paradigm of the structure-function relationship in
proteins and the connection of intrinsic disordered proteins (IDPs) with various diseases. In this
study, we undertake a systematic characterization of the thermodynamic and structural properties
underlying 15-mers of poly-K and poly-E under various conditions of pH, ionic strength and
solvent hydrophobicity. We found that, after interaction, oppositely-charged homopolypeptides
of this length remain as random coils at neutral pH in aqueous solutions with the interaction
being endothermic and strongly entropy driven. Increasing ionic strength does decrease their
affinity but does not change the sign of ΔS or ΔH. However, in more hydrophobic solvents the
sign of ΔH of interaction does change to an exothermic interaction. Moreover, the interacting
homopolypeptides showed secondary structure (β-sheet) in environments of much lower
hydrophobicity compared to the individual non-interacting homopolypeptides. 2-D NMR showed
that interaction occurred primarily via the side-groups with very little interaction between the
backbone amide groups. Furthermore, we found that there is a strong preference for the
polypeptide chains to bind in a parallel arrangement with the C-termini and N-termini aligned
with each other. We anticipate that these results will help improve our understanding of how
fundamental interactions between charged residues can result in both productive as well as
harmful protein structures.
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2.2 Introduction
Charged amino acids play a number of important roles in protein chemistry, including
protein stability, folding, ligand binding, and protein-protein interactions and are central to
function in intrinsically disordered proteins (IDP’s) 1-7. IDPs have not only been linked to
important biological processes 8-12 but also been implicated in several diseases 13, 14. However,
much less is known about the structure-function relationship of IDPs compared to structured
proteins. A key feature of IDPs are that they contain a relatively large content of charged amino
acids 15, with some regions containing up to ~15 residues with almost 100% charged
composition 16. Analyses of electrostatic interactions using continuum electrostatics models have
highlighted the importance of electrostatic complementarity in protein, peptide and nucleotide
binding 17. For example, longer arginine-rich peptides were found to bind to SiRNA more rapidly
than shorter peptides 18. In general, binding of IDPs’ to their molecular targets is characterized
by high-specificity and low-affinity 19. However, this description has been recently questioned in
the context of relating flexibility and complementarity 20. In this setting, it is important to
understand the relationship between electrostatic surface complementarity and binding affinity of
a protein/peptide to its molecular target(s) to better understand the interplay of structural forces
governing the binding specificity in IDPs.
It is also known that electrostatic interactions play an important role in the folding of
proteins and peptides 1, 21, 22. Computational studies on the folding of small and medium-sized
polypeptides have shown that folding thermodynamics and kinetics depend strongly on the
length of the peptide 23. Furthermore, protein misfolding is becoming an important focus due to
the link between several diseases with misfolded proteins. For example, it is known that tau and
prion proteins are associated with various neurological disorders when they misfold 24-26.
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Moreover, there is often not a clear distinction between IDPs and misfolded proteins,
complicated by the fact that disorder is often a precursor to misfolding, and some of the same
diseases are associated with both IDPs and misfolded, structured proteins; Alzheimer’s disease
being an important example 25, 26. Naturally, electrostatic interactions are expected to play
important roles in these proteins and associated diseases. Such interactions can be long range but
are distance and ionic-strength dependent, so factors such as protein and salt concentrations as
well as pH are expected to play important roles, and much work is still needed to quantify them.
In the current study, two oppositely-charged homopolypeptides are used as a model for
electrostatic-mediated protein binding. The homopolypeptides selected were 15-mers of poly-Lglutamic acid (polyE) and poly-L-lysine (polyK). While the biophysics of much larger versions
(>80 amino acids) of these peptides have been well-studied under various conditions, shorter
peptides, which are much more relevant to protein interactions, lack similar fundamental
biophysical studies. Long chains of polyK exhibit random coil structures at neutral and acidic pH
but are known to form α-helix structures in basic solutions, which can be transformed into β
sheets by gently heating 27. This polypeptide also adopts a α-helical structure in polar organic
solvents such as acetonitrile 28 and trifluoroethanol (TFE) 29. Long chain polyE is a random coil
at neutral and basic pH, a α-helix at acidic pH and can also transition into a β sheet when heated
30

. It is still unknown, however, how short versions of these polypeptides behave when titrated

together. Understanding the relationship between interaction thermodynamics and structure that
underlies specificity for complementary charged regions of proteins on the order of ~15 residues
is expected to provide valuable information on the structural forces that govern electrostatic
interactions in both structured and unstructured proteins. The interaction thermodynamics
between these homopolypeptides were studied using isothermal titration calorimetry (ITC) and

24

fluorescence resonance energy transfer (FRET) and the effects of the interactions on the
structural properties were studied using circular dichroism (CD) and nuclear magnetic resonance
(NMR) spectroscopy. FRET showed that the C terminus of polyK interacts with the C terminus
of polyE in a parallel arrangement. The interaction strength was found to depend strongly on the
pH and ionic strength of the aqueous solution. Interestingly, after binding, the polypeptides
remained largely as a random coil in neutral pH aqueous solutions although they showed some αhelical character in acidic or basic conditions. However, they formed β sheet secondary
structures when they interacted in TFE. This is in contrast to much longer versions of these
peptides, which were found to form β-pleated sheets in acidic or neutral aqueous solution, did
not interact in basic aqueous solutions and formed aggregates in less-polar solvents, which were
suggested to be α-helical structures 31. We were able to determine that electrostatic interactions
between side-chain groups plays a major role in the binding of these highly charged
homopolypeptides in aqueous solutions but in more hydrophobic environments (high TFE
concentration), hydrogen bonding interactions with backbone C=O and N-H groups play a
stronger role causing large secondary structural changes within the homopolypeptides.
2.3. Materials and Methods
2.3.1. Peptide Synthesis and Labeling
The far UV CD, NMR, and ITC experiments were carried out using 15-amino acid long
homopolypeptides (polyE and polyK) synthesized on a Perkins Elmer/ Applied Biosystems
433A synthesizer using “FastMoc” chemistry 32. The molecular mass of the homopolypeptides
were verified by ESI mass spectrometry. For fluorescence-based experiments, peptides with the
sequence E15C, E6CE9 and K14CK were ordered from Genscript to enable site-specific labeling
using maleimide chemistry 33. E15C or E6CE9 was labeled with the donor dye Alexa Fluor 488
(labeled polyE) and K14CK was labeled with the acceptor dye Atto 633 (labeled polyK).
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Labeling was carried out using a 5:1 ratio of dye to peptide in 10 mM phosphate buffer at pH
7.2. The mixture of peptide and dye, protected from light, were allowed to react overnight. The
unreacted free dye was separated out by dialysis using 2 kDa molecular weight cut-off dialysis
tubing (Spectrum Labs). The samples were dialyzed against 10 mM phosphate buffer for 24-48
hours with the external buffer being refreshed every 2-6 hours. The labeling efficiency was
verified by MALDI mass spectrometry (Bruker Ultraflex II TOF/TOF time-of-flight mass
spectrometer equipped with a MALDI ion source (Bruker Daltonik GmbH, Bremen, Germany)).
2.3.2. Circular Dichroism
Far UV circular dichroism experiments were performed using a Jasco J720
spectropolarimeter. Homopolypeptide (polyE and polyK) solutions were prepared in deionized
water. The final pH of the homopolypeptide solutions were carefully adjusted either using 1 M
HCl or 1 M NaOH. A 1:1 equimolar mixture of the homopolypeptides was prepared by mixing
100 L of 1 mM polyK, at room temperature, with 100 L of polyE. The desired pH of the
mixture was adjusted using HCl and NaOH, the pH meter was equipped with a microprobe.
Titration experiments with 2, 2, 2, trifluoroethanol (TFE) were carried out by mixing a 1:1
mixture of polyK and polyE with appropriate volumes of clean TFE. The resultant mixture was
readjusted to the desired pH. All far UV (190 nm – 250 nm) CD spectra were acquired, at room
temperature, using a 1 mm path length quartz cell. CD spectra were collected using a band width
of 1 nm and a scan speed of 50 nm/second and appropriate blank corrections were made in all
spectra.
2.3.3. Isothermal Titration Calorimetry
All isothermal titration calorimetry experiments were performed at room temperature
using VP-ITC (Micocal Inc.). 1 mM solution of polyK, placed in the reaction cell, was titrated
incrementally (in 6 L aliquots) with 10 mM solution of polyE (placed in the injecting syringe)
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with a 12 second interval between injections. The heats of the reaction per injection
(microcalories/second) were determined by integration of the peak areas using the Origin
software (version 7.0). The thermodynamic and binding stoichiometry values, characterizing the
interaction(s), were calculated by fitting the raw data using the fitting models provided in the
software. The best-fit of the data was judged based on the 2 values obtained on the individual
fits.
2.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy
NMR data were acquired at 25 C on a Bruker AVANCE 700 MHz spectrometer
equipped with a 5-mm triple resonance cryoprobe. 1 mM homopolypeptide (polyK and polyE)
solution was prepared in 5% v/v D2O + 95% v/v H2O. The final pHs of the solution(s) were
adjusted with either 1 M HCl or 1 M NaOH. Two-dimensional proton TOCSY and NOESY data
were acquired with 2048 data points in the F2 dimension and 512 increments in the F1
dimension. The spectral width was set to 12 ppm. TOCSY and NOESY spectra were acquired
with mixing times of 60 ms and 150 ms. NOE-based distance restraints were derived from 2D 1H
NOESY data obtained using different (200, 250, 300, and 350 ms) times. NMR spectra were
processed using XWIN-NMR and Sparky software 34.
2.3.5. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy
FRET measurements were made on a PTI Quantamaster 40. The concentration of labeled
polyE was set at 5.0 × 10-8 M. The concentration of labeled polyK varied from 5.0 × 10-10 to 1.5
× 10-6 M. The sample was excited at 470 nm and emission data were collected from 480 nm to
750 nm. The transfer efficiency was calculated by using the relative fluorescence intensity of the
donor at 516 nm in the presence (FDA) and absence (FD) of the acceptor 35 using: E= 1 –
(FDA/FD). The KD value was calculated by fitting to the Hill equation in Origin 36.
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2.4. Results and Discussion
2.4.1 Peptide Selection, Labeling and Characterization.
Cysteine residues were introduced in polyE either as the C-terminal most amino acid
(E15C) or in the middle of the peptide at position 7 (E6CE9) to examine the binding efficiency
and also probe the relative orientation of the interacting homopolypeptides. However,
introduction of a cysteine residue in polyK as the C-terminal most amino acid proved to be
technically challenging and therefore the cysteine was introduced as the penultimate residue
from the C-terminal end of polyK (K14CK).
The molecular mass and the location of the cysteine group were confirmed by MS/MS
data (figure 2.1) on the homopolypeptides. PolyE (E15C and E6CE9) and polyK (K14CK) were
tagged with fluorescent dyes Alexa 488 and Atto 633, respectively. MALDI mass analysis of the
purified florescent labeled homopolypeptides showed the expected molecular mass and verified
highly efficient labeling (figure 2.2).
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Figure 2.1. MS/MS of E15C, E6CE9 and K14CK. Top panel is for E15C, middle is E6CE9,
bottom is K14CK. These results show the various fragments (labeled B2 through B15) that
identifies the cysteine location via the change in mass upon removing each amino acid.
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Figure 2.2. MALDI-TOF MS of labeled peptides after purification. MALDI shows a single
peak highlighting complete labeling in a 1:1 dye: polypeptide ratio.
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2.4.2. Isothermal titration calorimetry (ITC) of polyE/polyK Binding
ITC is a powerful technique for the measurement of binding affinity 37, 38, stoichiometry
39, 40

, and the enthalpy and entropy changes 41, 42 governing interactions. The interaction between

polyE and polyK under different conditions of pH (pH – 2.0, 7.0 and 13.0) and salt
concentrations (100 mM, 250 mM, and 500 mM NaCl) was examined using ITC (figure 2.3).

Figure 2.3. ITC data for polyE/polyK binding in A) pH2, 0 mM NaCl; B) pH7, 0 mM NaCl;
C) pH13, 0 mM NaCl; D) pH7, 100 mM NaCl; E) pH7, 250 mM NaCl; F) pH7, 500 mM NaCl.
From N. Webb, Conformational Studies of Homopolypeptides.

Both polyK and polyE are charged at pH 7.0. The binding between the oppositelycharged homopolypeptides, at pH 7.0, is endothermic and proceeds with an overall increase in
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entropy. The binding isotherm is biphasic and best fits to a two–site binding model. The binding
occurs with an average binding constant (KD(app)) of 1.21 x 10-8 M (Table-2.1). The two observed
phases plausibly represent two discrete steps involved in the binding between the two oppositely
charged homopolypeptides. This suggests complex electrostatic interactions in which the
charged homopolypeptides interact differently at high concentrations than at low concentrations
in low ionic strength conditions, possibly via some cooperative aggregation process. The average
binding affinity between polyE and polyK at the extremes of pH (pH 2.0 and 13.0), wherein one
of the polypeptides is not charged, is reduced by 4-5 orders of magnitude to 5.75 × 10-3 M and
4.71 × 10-4 M, respectively. For binding interactions between the homopolypeptides at pH 2.0
and pH 13.0, the affinities are much weaker and so saturation was not observed, leading to
accurate values for the enthalpy and entropy of these interactions not being able to be quantified.
However, the sign of the enthalpy change is clear from the direction of change of the peaks
during titration. Interestingly, unlike at pH 7, binding interactions between the homopolypeptides
at pH 2.0 and pH 13.0 are exothermic.
Table 2.1. Thermodynamic parameters describing binding of polyE to polyK under various
conditions of pH and NaCl concentration as measured by ITC. From N. Webb,
Conformational Studies of Homopolypeptides.
Conditions

KD (M)

ΔH (kJmol-1)

ΔS (JK-1mol-1)

pH 2, 0 mM NaCl

5.75 × 10-3

N/D (-ve)

N/D

pH 13, 0 mM NaCl

4.71 × 10-4

N/D (-ve)

N/D

pH 7, 0 mM NaCl

1.21 × 10-8

7.2

50.8

pH 7, 100 mM NaCl

1.07 × 10-7

4.5
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pH 7, 250 mM NaCl

9.0 × 10-7

10.1

61.1
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ITC data were acquired at pH 7.0, as a function of ionic strength (0 mM to 500 mM
NaCl) to determine the nature of forces which are in play in the interaction between polyE and
polyK (figure 2.3 B,D,E,F). The binding affinity of the charged homopolypeptides was very
strong in the absence of salt (KD = 1.21 x 10-8 M). A progressive loss in binding affinity was
observed as the NaCl concentration was increased from 100 mM to 250 mM (figure 2.3 B,D,E,F)
The binding between the charged homopolypeptides was almost completely abolished at 500
mM. It should be noted that the ΔH and ΔS values are all positive at pH 7 and they are seen to
increase with increasing NaCl concentration.
In general, the decrease in binding affinity upon increasing the ionic strength suggests
that the interaction between the charged homopolypeptides, at neutral pH, is predominantly
electrostatic. The observed of lack of binding at 500 mM NaCl, even though at 250 mM the
binding is still relatively strong coupled with the weak but clear binding at pH 2 and pH 13
suggests that the binding mechanism is complex. While the ΔH changes to negative as the ionic
state of either polypeptide is changed through pH, these ΔH values remain positive as you
increase the NaCl concentration at pH7. All of this information together highlights this
mechanistic complexity and suggests that structural changes upon binding are different under the
different pH and NaCl conditions.
2.4.3. polyE/polyK Binding Studied by FRET
Fluorescence techniques have extremely high sensitivity, allowing for significantly lower
concentrations than are used in ITC. Moreover, due to the strong distance dependence of FRET,
careful placement of the dyes can provide information on the relative orientation of the
interacting homopolypeptides. By labeling polyE with the donor dye (Alexa 488), we were able
to measure the decrease in its signal when the acceptor-labeled polyK (Atto 633) was titrated
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into the solution. We used the same NaCl concentrations as for ITC, 0 mM to 250 mM NaCl.
Figure 2.4 shows the FRET data for the donor-labeled E6CE9 (figure 2.4A) and E15C (figure
2.4B) samples upon adding acceptor-labeled K14CK polypeptide. When the donor dye was
placed close to the center of the polyE chain (E6CE9), the FRET efficiency increased upon
adding polyK to a maximum value of ~0.4. At pH 7, in the absence of salt, the KD was found to
be 1.65 × 10-8 M, table 2.2. With addition of NaCl, the KD decreased to 5.37 × 10-8 M (100 mM),
and then further to 2.12 × 10-7 M (250 mM NaCl). The good agreement of the FRET data with
the ITC data is shown in figure 2.5, with only a slight variance in the samples that used salt. One
possible reason for this difference may be the concentration difference of polyE used in the
experiments (50 nM for FRET vs 500 µM for ITC) since in the FRET experiments the
concentration of the peptides approaches the KD value. Another possible reason is that for ITC
the data were not accurately fit by a single-site binding model, suggesting more complex binding
mechanisms could be present at the higher concentrations used in ITC. The data were fit using
both the Morrison equation and Hill equation in order to determine the binding coefficients.
Inspection of the fit curves and the χ2 values showed that the Hill equation fit the data much
better, although the KD values obtained using both methods were very similar (figure 2.4). It was
observed that the Hill coefficient was higher for the lower NaCl concentrations (n = 3 for 0 mM
and n = 1.4 for 250 mM NaCl), indicating that the binding cooperativity increased as the ionic
strength of the solution decreased. The most likely reason for this observation is that, at low ionic
strength and high polyK/polyE ratio, the lack of charge screening between the homopolypeptides
causes some degree of aggregation leading to multiple polyK’s binding to a single polyE, in
agreement with ITC observations. However, the maximum FRET value observed in figure 2.4A
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is the same 40% value independent of ionic strength, suggesting that, if aggregation does occur,
the additional dyes are outside the maximum FRET distance range.

Figure 2.4. FRET data fitted using Hill equation. Labeled polyK/labeled polyE binding at pH
7 with NaCl concentrations of 0mM (black), 100 mM (red) and 250 mM (blue) with different
donor dye placement positions on the polyE.
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Table 2.2. FRET conditions and binding constants for polyE/polyK.
Conditions

Sample

KD in M

0 mM NaCl, pH 7

E6CE9/ K14CK

1.65 x 10 -8 +/- 1.7 x 10 -9

100 mM NaCl, pH 7

E6CE9/ K14CK

5.37 x 10 -8 +/- 2.4 x 10 -8

250 mM NaCl, pH 7

E6CE9/ K14CK

2.12 x 10 -7 +/- 8.3 x 10 -8

0 mM NaCl, pH 7

E15C/ K14CK

2.53 x 10 -7 +/- 7.6 x 10 -9

100 mM NaCl, pH 7

E15C/ K14CK

3.50 x 10 -7 +-/ 2.2 x 10 -8

250 mM NaCl, pH 7

E15C/ K14CK

6.18 x 10 -7 +/- 3.74 x 10 -7

Figure 2.5. Comparison of KD measured using FRET (blue) and ITC (red). FRET data
comes from the dye in the middle position on the polyE peptide. Error bars are from the error
given in fitting.
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When the dyes were both placed on the C-terminus of the charged homopolypeptides
(figure 2.4B), two effects were discovered. First, the maximum FRET efficiency that was
observed was much higher that when the donor dye was close to the center of the polyE chain
(~0.9 vs. ~0.4). This indicates that the peptides are bound in a parallel arrangement bringing the
donor and acceptor dyes into very close proximity. An antiparallel disposition of the
homopolypeptides would have resulted in a lower FRET value that observed in figure 2.4A.
Second, the KD values were reduced for the E15C samples compared to the E6CE9 samples at
each given concentration of NaCl indicating that the binding was weaker when the dyes were
forced to be close to each other. This also indicates that the preference for a parallel assembly
must be so strong that the steric hindrance from the dyes was not able to force the peptides to
bind in an anti-parallel arrangement.
2.4.4. Far-UV CD spectroscopy of equimolar mixtures of polyE and polyK
Far-UV CD spectroscopy is a powerful method to determine secondary structural
information. However, the far-UV CD spectrum is an ensemble-averaged signal from all
conformations in the sample and requires careful deconvolution to quantitatively estimate the
constituent secondary structural elements 43. Nevertheless, changes in the average structure can
be assessed by measuring the spectral changes at certain wavelengths (or ratios of wavelengths)
upon binding or changing environmental parameters. The far-UV CD spectra of an equimolar
mixture of polyE and polyK were acquired at pH values ranging from 1-14 (figure 2.6A, B). The
CD spectra showed significant backbone disorder under all pH conditions. The 222/208 nm ratio
is higher for α-helices than random coils and a plot of mean residue ellipticity ratio (222 nm/208
nm) versus pH (figure 2.6B) for the bound polyE/polyK did show some α-helical content at
extreme pH values (pH 1 and pH 14). Studies of long-chain polyK homopolypeptides 31 shows
that, at high pH, they show α-helical secondary structure, while polyE is expected to be
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disordered. At low pH, the converse is true; polyE forms a α-helix 44 and polyK is disordered.
However, we find that, for 15-mer homopolypeptides, they are largely unstructured at all pH’s,
although there is a minor contribution from α-helix structure at extreme pH, as evidenced from
figure 2.6.

Figure 2.6. CD spectra of polypeptides in water or TFE. A) Far-UV CD spectra of an
equimolar mixture of polyK and polyE in water at pH 2 (black), pH 4 (blue), pH 6 (pink), pH 8
(green), and pH 13 (cyan). B) Mean residue ellipticity ratio (222 nm/208 nm) as a function of
pH. C) Far-UV CD spectra of the summation of the individual polyK and polyE spectra at pH 2
(blue), pH 7 (black), and pH 13 (pink). D) Far-UV CD spectra of an equimolar mixture of polyK
and polyE at pH 7 in TFE/H2O at 0% v/v (black), 12% v/v (blue), 30% v/v (pink), 45% v/v
(purple), 75% v/v (green), and 90% v/v (cyan). E) Change in mean residue ellipticity at 195 nm
versus concentration of TFE (v/v). F) Far-UV CD spectra of the summation of the individual
polyK and polyE spectra at 0% v/v (black), 50% v/v (blue), 75% v/v (pink), and 90% v/v
(purple). From N. Webb, Conformational Studies of Homopolypeptides.
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In order to follow the secondary structural changes of polyE and polyK upon binding,
far-UV CD spectra of individual 15-mer polyE and polyK were separately measured at low,
intermediate, and high pH and the summation of these individual spectra are shown in figure
2.6C. Comparing figure 2.6A and 2.6C for CD, the ellipticity minima at 208 nm and 222 nm are
slightly more defined in the summation of individual polyE and polyK spectra at extreme pH
(figure 2.6C) than that observed for an equimolar mixture of the homopolypeptides at the same
pH (figure 2.6A). These results suggest that, upon interaction of the homopolypeptides, the
already low propensity for α-helix formation at low and high pH is reduced even further.
Electrostatic interactions are strengthened in solvents with low dielectric constants such
as 2,2,2-trifluoethanol (TFE). In this context, the effect of dielectric of the medium was
examined by treating an equimolar mixture of the polyE/polyK at pH 7.0 with different
percentage concentrations of TFE v/v. Interestingly, although TFE is primarily considered to be
an α-helicogenic solvent, addition of moderate TFE concentrations (~20% v/v) caused a
transition of the bound polyE/polyK from primarily random coil to increased β-sheet structure
(figure 2.6D). This is exemplified by the presence of a weak negative band centered near 216 nm
and a strong positive band at 195 nm 45. To quantify the amount of β-sheet present in the
equimolar polyE/polyK mixture the change in mean residue ellipticity at 195 nm was plotted as a
function of TFE concentration (figure 2.6E).
As mentioned above, both polyE and polyK exist as random coils at pH 7. The spectra
resulting from the summation of the individual spectra for polyE and polyK in increasing
concentrations of TFE at pH 7 is shown in figure 2.6F. As expected, the spectra obtained by
summation of the individual spectra for polyE and polyK reflect largely random coil structures
below 75% v/v TFE concentrations and α-helical conformations above 75% v/v TFE. However,
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when polyE and polyK were bound together, the CD spectra showed β-sheet rather than α-helical
structure. Interestingly, much lower concentrations of TFE were required to induce a random coil
to structured (β-sheet) transition in the bound homopolypeptides compared to the individual
isolated homopolypeptides. A significant change in the mean residue ellipticity at 190 nm of the
far-UV CD spectra of the equimolar polyE/polyK mixture was found between 0-20% v/v TFE.
This much lower hydrophobicity threshold for interacting short-chains of polyE/polyK to form
secondary structure may have significant implications in the binding-folding hypothesis of IDPs
46

.

2.4.5. TOCSY and NOESY NMR Spectroscopy
Total Correlation Spectroscopy (TOCSY) is a nuclear magnetic resonance (NMR)
spectroscopy technique used to correlate all the protons of a spin system. The resulting spectrum
shows a specific pattern of crosspeaks for each amino acid. Nuclear Overhauser Enhancement
Spectroscopy (NOESY) produces a crosspeak for each pair of nuclei that are coupled through
space. The intensity of the NOESY crosspeaks depends on the inverse of the distance between
the nuclei to the sixth power (1/r6). The combination of these two techniques provides atomiclevel information on the nature of interactions between the charged homopolypeptides.
TOCSY and NOESY spectra were first acquired for the isolated homopolypeptides to
unambiguously assign all the resonances. TOCSY and NOESY spectra for the polyE and polyK
individually are shown in work done with our colloborator47, together with predicted chemical
shifts. The TOCSY and NOESY spectra of the polyE/polyK mixture for two regions are shown
in figures 2.7A and B. Three potential NOEs were observed. Two NOEs are indicated by the
number “1” in figure 2.7A. Since the intensity of the NOE crosspeaks increases further
downfield in the NOESY spectrum, the NOEs can be attributed to interactions between the
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backbone N-H groups of the two charged homopolypeptides. For the NOE peak labeled as “2” in
figure 2.7B, the intensity of the peak(s) increases further up field in the NOESY spectrum
suggesting that the NOE represents the interaction between the Hε of polyK and Hγ of polyE.
This observation of NOEs shows that the polyE/polyK mixture primarily interacts via the
electrostatic interactions between the oppositely charged side-chain groups of the two
homopolypeptides, with only weak contributions from backbone H-bond interactions. These
NMR results support and help explain the observations from the CD spectra that polyE and
polyK have very little secondary structure upon their interaction.
ppm

A
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K-γH
K-δH
K-δH
E-βH
E-βH
K-βH
E-γH
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1

1
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2
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B

Figure 2.7. TOCSY (blue) and NOESY (red) NMR spectra of polyE/polyK mixture at pH 7.
The light gray lines in A are for visual reference. From N. Webb, Conformational Studies of
Homopolypeptides.

41

2.4.6. Combining Structural and Thermodynamic Data
The CD and NMR data provide some structural basis for the thermodynamic observation
that the ΔH and ΔS are both positive upon binding at pH7 independent of the salt concentration,
and that the binding is exothermic at the extremes of pH. The bond energy between the charged
groups and the multiple solvent molecules or ions is relatively strong and this bond energy is not
completely balanced by the newly-formed salt bridges between the K and E groups. However,
the entropy strongly increases when solvent/ions that interact with the charged groups of polyK
and polyE are released into the bulk providing the major driving force for the interaction.
Clearly, the entropy decrease upon bringing together the two relatively small homopolypeptide
chains together is more than made up for by this release of solvent/ions into the bulk. Naturally,
as ionic strength increases, this argument holds since the only effect of the additional ions is to
screen the interactions without affecting the overall structure. It seems that more solvent/ions are
released when the chains bind in a parallel arrangement suggesting that the geometry of the
chains play a role in the solvent/ion interactions. At the extremes of pH, where one of the
homopolypeptides is uncharged, solvent molecules or ions interact less strongly with the polyK
(at pH13) or polyE (at pH2). Bond energy is released by the ionization of the uncharged residues
to form the salt bridge upon interaction. Although it was not quantified, one may expect that the
entropy decrease from the interaction of the two chains is not as strongly balanced by the release
of less solvent/ions into the bulk, leading to a more enthalpic-driven process.
2.5. Conclusions
We have presented a combined thermodynamic and structural study to better understand how
oppositely-charged amino acids in short chain polypeptides interact. This interaction is measured
when both polypeptides are charged or when one or both of them is/are made to be uncharged by
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changing pH or solvent hydrophobicity. The main conclusions drawn from this combined study
are as follows:
1) When the ionization state of 15 amino acid homopolypeptides are both charged they are
random coils and remain as random coils after their high-affinity interaction. The
interaction is strongly entropy driven by releasing solvent/ions into the bulk.
2) Upon changing the ionization state of 15-mers of polyE or polyK by pH, they maintain a
great deal of random coil behavior both before and after interacting. There is a slightly
increased propensity for individual polyE in low pH aqueous solvents and for individual
poly-K in high pH aqueous solvents to form α-helical structures but this is reduced once
they interact.
3) There is an increased propensity for individual 15-mers of polyE and polyK to form αhelical secondary structure in hydrophobic solvents such as TFE, but requires high
concentrations (>75% v/v) to do so. After interaction, polyE and polyK form β-sheets
under mildly hydrophobic conditions (<20% v/v TFE).
4) Although they remain as random coils after binding, there is a strong preference for the
homopolypeptide chains to bind in a parallel arrangement in aqueous solvents with the Ctermini and N-termini aligned with each other.
The conclusions from this study helps expand our understanding of fundamental interactions
between charged residues in highly acidic or basic regions of proteins on the scale of ~15 amino
acid, which play important roles in regulation of protein interactions as well as underlie
structure-function relationships in IDPs. Eventually, such knowledge may help us to determine
the conditions that can result in both productive as well as harmful protein structures involving
highly charged regions of proteins.
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dissertation.
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III. Determining the Effects of Fluorescent Labels on Electrostatic Interactions using a
Polypeptide Template

3.1. Abstract
The uses of fluorescent dyes are widespread in biolabeling experiments. There are many
different types of fluorescent dyes available consisting of different structural classes, sizes and
charges. We have investigated these varying effects of on the apparent binding affinity
associated with charge-charge interactions. We have designed a system consisting of two
homopolypeptides that bind primarily through electrostatic interactions with a preferred
orientation that allows us to place the dyes so that they come very close to each other during
binding. By attaching fluorescent dyes to these peptides, we are able to compare the binding
affinity for various dye pairs through FRET to quantify which of the various dye properties are
the most important to consider. Through this approach, we were able to show that the charge of
the dye can be as important as the size or structure of the dye, even though this property is not
usually considered as strongly by researchers during dye selection. By using dyes too close
together, you can decrease the apparent binding affinity as well as the positive cooperativity of
your binding partners.
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3.2. Introduction
Fluorescent dyes are used in a wide range of biological and biophysical applications. One
of the most common uses involve biolabeling studies to track protein movement1-3, visualize cell
compartments4, 5, study protein folding6-10, and measure binding between ligands and proteins11.
The most common structural motifs of fluorescent dyes used in biolabeling studies are
coumarins, cyanines, xanthenes (fluorescein, eosin, and rhodamine), BODIPYs, oxazines and,
more recently, carbopyronin, with each of the structural types having specific properties that
determine how they can be used. Absorption and emission wavelength, molar absorptivity,
quantum yield and photostability are the most important characteristics to determine suitability
for a specific application. For example, it is known that solvent viscosity affects the quantum
yield of cyanine dyes12 and this property has been employed as a method to measure binding
between biomolecules at very close distances13-15. For FRET studies, the emission wavelength
and the quantum yield of the donor, together with the absorption wavelength and molar
absorptivity of the acceptor, determine the sensitive distance range probed during biomolecular
interaction studies. However, other dye properties such as size, molecular structure and charge
could also be important in probing such interactions, although they are usually less carefully
considered during selection. In order for accurate conclusions to be drawn from experimental
data, all such contributions from the fluorescent dyes should be examined and quantified.
The use of fluorescent dyes attached to proteins allows one to measure binding
coefficients between protein and ligand with high sensitivity. They are currently used to study
DNA-ligand binding16, RNA targeting in cells17, and even heterogeneity of binding sites in
stressed monoclonal antibody formulation18, among many others19. Currently in the literature,
there is a very limited amount of papers that address the importance of dye charge and size
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properties on experimental results. It has recently been shown that dye charge20 and certain
functional groups on a dye21can have an effect on measured diffusion coefficients within a
charged environment but little data exists as to how the charge affects biological binding,
although some researchers have noted that using certain dyes can show different binding
conformations depending on the protein/dye interaction under study22. Dyes can also cause steric
hindrance when proteins are folding and force the protein to fold to an un-native conformation23.
It has also been shown that dyes that are in close proximity can quench each other, and mislead
researchers with faulty data24. In this study, we are particularly interested in quantifying the
effect of the dye as it pertains to measuring the binding coefficient for interactions between
charged residues, since such residues are important for long-range and short-range interactions in
both structured proteins and intrinsically disordered proteins (IDPs).
In order to determine specific effects related to the structure, size, and charge of a
fluorescent dye on charge-charge interactions, we have developed a system to change each of
these parameters in a well-controlled biomolecular template. By using two polypeptides that bind
in a parallel arrangement regardless of dye position (chapter 2), we place the dyes so that they
are forced to come into close proximity of each other. One peptide contains 15 lysines (PolyK)
that bind to a partner with 15 glutamic acids (PolyE). This system is well-suited for measuring
the effects of different dyes on binding because these two peptides interact primarily though
electrostatic interactions (chapter 2). By employing FRET, we compare the effects of various dye
pairs on the binding coefficients for this peptide template system by changing the dyes on each
of the peptides. We have determined that the choice of dye has a strong effect on the measured
dissociation constant, KD. If the bulky carbopyronin-based acceptor, Atto 633, which carries a +1
charge, is used, the measured affinity is significantly lower than the actual affinity (independent
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of whether a +1 or -1 charged donor is used) but if the small, neutral BODIPY is used as the
donor, the bulkiness and charge effect of the Atto 633 is negated. On the other hand, if the large
but zwitterionic xanthene-based Atto590 is used as the acceptor, the measured KD value is only
slightly higher than the actual KD value, and is independent of the size or charge of the donor.
The results of this study shows that both the size and charge of the dyes must be considered
when making decisions about which dye pair to use for quantitative FRET studies in situations
when the dyes will be close to each other.
3.3. Materials and Methods
3.3.1. Peptide Labeling
Peptides with the sequence E15Cand K14CK were ordered from Genscript to enable sitespecific labeling using maleimide chemistry25. E15C was labeled with the donor dye (termed
PolyE) and K14CK was labeled with the acceptor dye (termed PolyK). Labeling was carried out
using a 5:1 ratio of dye to peptide in 10mM phosphate buffer at pH 7.2. The mixture of peptide
and dye, protected from light, were allowed to react overnight. The unreacted free dye was
separated out by dialysis using 2 kDa cut-off dialysis tubing (Spectrum Labs). The samples were
dialyzed against 10mM phosphate buffer for 24-48 hours with the external buffer being refreshed
every 2-6 hours. The labeling efficiency was verified by MALDI mass spectrometry (Bruker
Ultraflex II TOF/TOF time-of-flight mass spectrometer equipped with a MALDI ion
source)(Bruker Daltonik GmbH, Bremen, Germany).
3.3.2. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy
FRET measurements were performed on a PTI Quantamaster 40. The concentration of
labeled PolyE was set at 5.0 × 10-8M. The concentration of labeled PolyK varied from 5x10-10 to
1.5 × 10-6 M. The sample was excited at either 470 nm (Alexa 488 and Bodipy) or 515 nm (Cy3)
and emission spectra were collected from 480 nm to 750 nm (Alexa 488 and Bodipy) or 525 nm
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to 750 nm (Cy3). The energy transfer efficiency was calculated at each concentration of
acceptor-labeled peptide added by using the relative fluorescence intensity of the donor peak in
the emission spectrum in the presence (FDA) and absence (FD) of the acceptor using equation 126
E= 1 – (FDA/FD).

(1)

The KD value was calculated by fitting the FRET data to the Hill equation (equation (2)) in
Origin 8.127.
E = (Emax*[PolyK]n ) / (KDn + [PolyK]n)

(2)

3.4. Results
Figure 3.1 shows a schematic of the two labeled polypeptide chains as they bind. We
showed in Chapter 2 that a parallel orientation is the favored interaction for the
homopolypeptides between the charged side chains of glutamate and lysine. In this orientation,
the donor and acceptor dyes are forced into close proximity of each other. The general structures
of the dyes used in this study are shown in figure 3.2 and the source of each dye is given in table
3.1. The cyanine dyes are large with two fused ring structures capping a linear conjugated chain,
leading to a moderate amount of structural flexibility. The xanthene dyes contain four 6membered rings in a T-shape, together with several side groups on the rings and are much more
rigid. The bodipy dye is much smaller than the others, containing a fused 6-membered and two
5-membered rings with no side groups.
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Figure 3.1.Schematic of homopolypeptides binding. The Poly E and Poly K peptides align
parallel to each other so that the effect of the close proximity of the dyes can be evaluated.

Figure 3.2.General structures of the dyes used. A) Cy3 is bulky but somewhat flexible. B)
BODIPY is rigid but very small. C) The xanthene dyes (Alexa Fluor 488 and Atto 590) are very
bulky and rigid. D) Carbopyronin dyes are also bulky and rigid (Atto 633).

Table 3.1.Full dye name, manufacturer, product number, and structural motif for all dyes
used.
Dye Name
Alexa Fluor 488
Atto 590
Atto 633
Bodipy FL
Cyanine3

Company
Molecular Probes
Atto-Tec
Atto-Tec
Molecular Probes
Lumiprobe

Product Number
A-10254
AD 50-41
AD 633-41
B-10250
11080

Structural Motif
Xanthene
Xanthene
Carbopyronin
BODIPY
Cyanine
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Using FRET, we measured the binding affinities between the two homopolypeptides
labeled with different dyes and under different conditions. We varied the NaCl concentration
from 0 mM to 250 mM at pH 7.2. Figure 3.3 shows a decrease in binding affinity as the
concentration of salt is increased, as expected for electrostatic interactions (chapter 2). A similar
trend is seen in all dye-pairs studied. The KD values of all of the dye pairs that we examined are
collated in Table 3.2. We have chosen dyes that we can pair together to investigate structural and
size effects as well as charge effects. The salt concentration, Hill coefficients and maximum
FRET values (Emax) are also shown in Table 3.2.
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Figure 3.3.FRET curves at different NaCl concentrations: 0 mM (blue), 100 mM (red) and
250mM (purple). With increasing salt the slope of the curve decreases, consistent with the
binding between the peptides being primarily electrostatic.
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Table 3.2.Measured binding parameters for the different FRET dye pairs. Dyes carried
either a +1 charge, -1 charge, were zwitterionic (+/-) or were neutral (0).
Dye Pair (D/A)

Acceptor
Charge
+1

[NaCl]

KD

Alexa 488/Atto 633

Donor
Charge
-1

253 +/- 7.2

Hill
Coefficient
4.4

Maximum
FRET
.86

0

Alexa 488/Atto 633

-1

+1

100

350 +/- 22

2.0

.90

Cy3/Atto 633

+1

+1

0

348 +/- 13

3.0

.93

Cy3/Atto 633

+1

+1

100

578 +/- 24

1.3

.88

Alexa 488/Atto 590

-1

+/-

0

103 +/- 15

5.0

.80

Alexa 488/Atto 590

-1

+/-

100

48 +/- 5

2.2

.78

Cy3/Atto 590

+1

+/-

0

94 +/- 5

4.2

.78

Cy3/Atto 590

+1

+/-

100

65 +/- 4

2.6

.69

Alexa 488/ Cy3

-1

+1

0

67 +/- 3.5

2.8

.74

Alexa 488/ Cy3

-1

+1

100

35 +/- 1.4

2.0

.63

Bodipy/ Atto 633

0

+1

0

49 +/- 2.3

2.9

.79

Bodipy/ Atto 633

0

+1

100

90 +/- 5.3

3.1

.70

Bodipy/ Atto 590

0

+/-

0

85 +/- 3.1

4.0

.84

Bodipy/ Atto 590

0

+/-

100

75 +/- 3.9

4.2

.43

In figure 3.4, the differences in KD values are plotted for each of the dye pairs at 0 mM
and 100 mM NaCl. We also collected FRET data for all samples at 250 mM NaCl, but the much
weaker binding between the polypeptides at this salt concentration precluded the data from being
accurately fit (figure 3.3). Along the bottom axis, the data are sorted by the charge on the
acceptor dye. The control KD value was obtained by ITC on unlabeled polypeptides and found to
be 12.1 nM at 0 mM NaCl and 107 nM at 100 mM NaCl (chapter 2). In the case of the acceptor
dye being a zwitterion, the measured KD values did not vary much between the differently
charged donor dyes with KD = 103 nM (donor with -1 charge), KD = 94 nM (donor with +1
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charge), and KD = 85 nM (neutral donor) at 0 mM NaCl. This is only slightly larger than the
control value. In contrast, when an acceptor dye with a +1 charge was used, the KD values varied
widely depending upon the charge of the donor. When the donor was neutral, the KD value was
comparable to the control with KD = 49 nM at 0 mM NaCl. When the donor carried a +1 charge,
KD=348 nM at 0 mM NaCl, while the donor carrying a -1 charge had KD=253 nM at 0 mM
NaCl. When the concentration of NaCl was increased to 100 mM, the control KD decreased by
about 1 order of magnitude compared to that at 0 mM NaCl. At 100 mM NaCl, the zwitterionic
acceptor showed KD values that still did not depend on the charge on the donor, but did not
become weaker at 100 mM NaCl, as the control did; KD = 65 nM for the donor with a +1 charge
and KD = 48 nM for the donor with a -1 charge. However, when the +1 charged acceptor was
used at 100 mM NaCl, the affinity did decrease compared to 0 mM, whether the donor carried a
+1 (KD = 578 nM) or a -1 charge (350 nM), although the factor of the decrease was not as much
as for the control. With the +1 charged acceptor and the neutral donor KD = 90 nM, effectively
the same as the control.
Due to the fact that the effect of the charge on the dye showed some unexpected
behavior, such as oppositely-charged dyes not always leading to an increased affinity and that
increasing the NaCl concentration did not always decrease the affinity, the effect of the dyes’
structure was also considered as a potential source for the effect. Depending on commercial
availability, one can keep the charge on the acceptor as +1 but use different structural motifs. In
the case of the -1 charged donor (the xanthene-based Alexa Fluor 488), we compared a +1
charged acceptor with either the very similarly structured carbopyronin-based structure of Atto
633 or the somewhat differently structured cyanine-based structure of Cy3. When the smaller,
slightly more flexible cyanine dye was used as an acceptor the KD value at 0 mM NaCl was 67
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nM compared to 235 nM for the larger, more rigid carbopyronin dye acceptor. At 100 mM NaCl,
the KD values for the cyanine and carbopyronin acceptors were 35 nM and 350 nM, respectively,
effectively the same as at 0 mM NaCl.

0 mM NaCl
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(+1) Donor
(-1) Donor
(0) Donor
Control
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Figure 3.4.KD values for dye pairs as a function of charge. The +1 charged acceptor was
either the rigid Atto 633 or the slightly flexible Cy3 (denoted by **), whereas the +1 charged
donor was only Cy3 (see table 1).The control data was obtained by ITC without dyes29.

Figure 3.5 highlights the difference in the Hill coefficients based upon the charges on the
dye pairs and the salt concentration. When the acceptor is zwitterionic, the Hill coefficient does
not depend on the charge of the donor, the Hill coefficient stays high, between 4 and 5 for all
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donors. The Hill coefficient was also similarly high for the -1/+1 D/A dye pair as well. When the
acceptor has a +1 charge and the donor’s charge is either neutral or +1, the Hill coefficients are a
little lower at ~3. Clearly, at 0 mM NaCl, the Hill coefficient is >1 for all dye pairs. In all but one
case, the Hill coefficient decreases to ~2 as the concentration of salt increases to 100 mM. The
dye pair where the donor is neutral and the acceptor has a +1 charge does not decrease at 100
mM NaCl, remaining at ~3.
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Figure 3.5. Comparison of Hill coefficient for every dye pair with varying NaCl
concentration. ** denotes when the +1 charged acceptor was Cy3 rather than Atto 633.
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Finally, we quantify the maximum change in FRET (Emax) at the saturating concentration
of acceptor-labeled PolyK for each of the dye pairs at 0 mM and 100 mM NaCl in figure 3.6. All
of the Emax values at 0 mM NaCl are high (above 0.7), with most between 0.8 and 0.9.
Interestingly, the D/A pair consisting of +1 xanthene/+1 xanthene shows the highest Emax value,
while the D/A pair consisting of +1 xanthene/+1 cyanine shows the lowest Emax value. All the
other dye pairs show effectively the same Emax value (between 0.80 and 0.85) independent of dye
charge and structure. At 100 mM NaCl, the Emax values are still high (above 0.6), but show
slightly more variability.

0 mM NaCl

1.0

100 mM NaCl
(+1) Donor
(-1) Donor
(0) Donor

Maximum FRET

0.8

0.6

0.4

0.2

0.0
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(+1)
(+1)
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Ac c e
Acce
Acce
Acce
Acce
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ptor
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ptor
ptor*
ptor
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Figure 3.6.Maximum FRET value for dye pairs. ** denotes when the +1 charged acceptor
was Cy3 rather than Atto 633.
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3.5. Discussion
The central focus for this work was to determine if the choice of fluorescent dyes that are
commonly used in FRET-based binding studies affects the results when electrostatic interactions
are being probed. We purposely chose conditions in which the dyes are forced into close
proximity of each other to determine the worst-case scenario. We have developed a
homopolypeptide template system that forces this condition. It is clear from our results that,
when the fluorescent labels come into close proximity of each other, they do have an effect on
the measured KD values, although the effects are not as clear cut as one might anticipate. They
depend on the size, charge, and structure of the dye label in varying degrees, which further varies
with the ionic strength of the solution in which binding is studied. The control KD value for the
binding of our peptides (PolyE + PolyK) was obtained by ITC, without using fluorescent labels,
(Chapter 2) to enable absolute effects rather than relative effects to be quantified. At 0 mM NaCl,
all of the KD values that were quantified using fluorescent labels showed weaker binding than the
control although some dye combinations has only a marginal effect. The decrease in binding
most likely arises from steric hindrance from the dyes interfering with the peptide interaction.
The degree of the steric effect depends on both the size/rigidity of the dye as well as the charge.
The peptides still bind very tightly (KD<100 nM in most cases) because there are still effectively
15 charges on each peptide that attract each other. If the commonly used carbopyronin-based
acceptor, Atto 633, which carries a +1 charge, is used, the measured affinity is significantly
lower than the actual affinity (control value) when either the +1 charged Cy3 or the -1 charged
Alexa Fluor 488 is used as the donor, with the +1/+1 dye combination being ~40% weaker than
the +1/-1 dye combination, even though Cy3 is more flexible than Alexa Fluor 488. However, if
the small, neutral BODIPY is used as the donor, the bulkiness and charge of the Atto 633 is
negated, with the measured KD value being almost the same as the actual KD. On the other hand,
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if the large, rigid but zwitterionic xanthene-based Atto590 is used as the acceptor, the measured
KD value is only a little higher than the actual KD value, and is independent of the size or charge
of the donor. For the situation when commercial availability allowed us to keep the charge on
both the donor and acceptor the same (but complementary to each other) but change the dye
structural motif, the bulkiness/rigidity effects can be studied. Comparing Alexa Fluor 488 (1)/Atto 633(+1) vs Alexa Fluor 488 (-1)/Cy3(+1), we can see that the Alexa Fluor 488/Cy3 pair
was much closer to the actual KD value, being very similar to the cases in which the zwitterionic
xanthene-based acceptor was used. Clearly the complementary dye charge is not enough to
overcome the bulkiness of the carbopyronin-based Atto 633, whereas it is enough for the cyanine
dye. It is possible that the flexibility of the cyanine dye allows it to be pushed into a position to
allow the homopolypeptides to bind in a more natural way.
When 100 mM NaCl is added to the buffer, the actual KD value for the homopolypeptide
binding is increased, as expected for electrostatically-mediated interactions (chapter 2).
However, only the situations in which the carbopyronin-based Atto 633 was used as the acceptor
showed an increase in measured KD, and these were still much higher than the actual KD value at
100 mM – except when BODIPY was used as the donor. In this case, BODIPY again allowed us
to measure the actual KD value, as was the case at 0 mM NaCl. Clearly, BODIPY is an excellent
choice of dye when dyes must be placed close to each other. Interestingly, when the zwitterionic
Atto 590 or the cyanine Cy3 was used as the acceptor, no effect of increasing NaCl to 100 mM
was observed. Since the KD value for these situations in 0 mM NaCl was very similar to the
actual KD value at 100 mM, perhaps the increased salt concentration negated the remaining dye
effect, although more experiments will be needed to confirm this possibility.
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The Hill coefficient is a measure of positive interactions. For simple, sequential binding,
the Hill coefficient (n) should be less than 2. In all cases at 0 mM NaCl, n>2. This suggests that
the binding of the peptides is not a simple model in the sense that 2 peptides come together and
bind. What is more likely happening is small clusters of peptides are forming. The hill
coefficient values behave proportionally to the KD values, i.e. as the KD value shows weaker
binding, the n value shows less positive cooperativity. These effects are from the size of the dye
as well as the charge. When the bulky dye causes steric hindrance, it not only reduces the
binding affinity but it also stops the peptides from forming the tightly bound small complexes.
The charges act in the same way, the repealing charges won’t allow the peptides to bind as
tightly as they would otherwise.
Under the conditions of 100 mM NaCl, the n values are lower which is to be expected
since the peptides interact through electrostatic interactions. In some cases, n<2, mainly when the
KD value was very high. The same conditions apply here as in the 0 mM NaCl conditions, the
dye is keeping the peptides from binding and forming the complexes that increase the Hill
coefficient. When the BODIPY dye is used however, the n value stays very close to the same
regardless of the salt concentration just like with the binding affinity. This neutral dye is has the
minimal effect on the binding and stacking of the peptides.
When analyzing the Emax values, a clear trend becomes apparent for both the 0 mM and
the 100 mM NaCl experiments. In the peptide complexes that bind less tightly and have less
positive cooperatively, the maximum FRET value is higher. Since the FRET is a measure of
quenching, it can be presumed that the large complexes reduce the apparent quenching, by either
peptides donating electrons to increase the quantum yield of the donor or by the
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closeness/number of dyes present. Further experiments are needed to accurately ascertain which
phenomenon is occurring.
3.6. Summary and Conclusions
With all of the fluorescent dye choices available, it is important to consider the system in
which the dyes will be used. In FRET studies, the dyes are quiet often placed near a binding site
in order to get high FRET values upon the binding of a ligand. We have shown that putting the
dyes in an arrangement so that they come in very close contact with one another can be
detrimental to the accuracy of the results. All parameters explored in this study, binding affinity
and cooperativity, where affected by the nearness of the donor and acceptor dyes. In instances
where the experimental design does not allow for options other than extremely close dye
placements, it would be advisable to use small, neutral dyes to mitigate the effects the dyes
cause, like decrease in binding and loss of positive cooperativity. At this point, the decrease in
the Emax value is not clear and future work will need to be performed to help answer this
question.
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IV. Insights on the Quenching of Some Fluorescent Dyes Commonly Used in Biolabeling by
Charged Amino Acid Residues

4.1. Abstract
The use of fluorescent dyes in biolabeling studies has greatly increased in the past several years.
One very popular method of measuring protein binding using fluorescent dyes is by FRET since
it can be used to extract structural details due to its well-known distance dependence. We have
determined that changes in the immediate environment of the dyes caused by binding of charged
residues can affect the quantum yield of these dyes via quenching which will affect the extracted
structural parameters. The effects of the charged environment are also determined by the charge
of the dye used. If the fluorescent dyes must be used in the very near vicinity of charged
residues, very careful consideration should be used in selecting the dye and the method of
measurement.
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4.2. Introduction
Fluorescent dyes have been used for many years for a myriad of different applications
from protein labeling and assays with DNA to individual proteins measured on a single molecule
basis1-4. There is such a broad range of fluorescent dyes available and it is important to know
which will best suit the needs of the system being probed. Several reviews have been published
that describe various aspects of available fluorescent dyes and their uses5-7. Some of the most
commonly used dyes include rhodamines, which have been used for labeling human cardiac
tissue for use in imaging8, BODIPY’s, which have been used to probe lipids in microalgae9, and
coumarins, fluoresceins, and oxazines that are used for fluoride sensing in cellular systems10. All
of these dye types are popular because they have high stability and long fluorescent lifetimes11,
12

.
Sometimes it is necessary to use fluorescent dyes in environments that are not the most

ideal; e.g. near to highly charged regions of a protein or near to a binding site. Since most dyes
have a charge themselves, the combination of these factors could pose a problem for obtaining
accurate results. Others have started to investigate the effects of fluorescent dyes on results, from
the charge of the dye interacting with glass surfaces13, to trying to distinguish between
observable protein folding and dye photophysical induced data14. Dye effects have also been
noted in studies of nucleic acids15. In microarray work, dye bias can lead to over estimations in
expression levels16.
Our lab has been particularly interested in studying charge-charge interactions in
biomolecules (chapters 2 and 3), and we have been developing fluorescence-based assays to
study the binding affinity and orientation between oppositely-charged homopolypeptides. We
have also studied the effect of putting differently sized and charged dyes very close to each other
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and the interaction. The results of that study concluded major differences in binding affinities
due to the dyes’ interaction. In those studies, the reduction in the fluorescence intensity of a
donor dye was used as a probe for interaction between oppositely-charged homopolypeptides.
However, we did not expand upon which quenching mechanisms were responsible for the
fluorescence decrease. The affinity can be determined without such knowledge, but in order to
gain additional information from these experiments, such as interfluorophore distances that can
be used to extract structural details, it is necessary to determine which mechanisms are
responsible for quenching. For example, quenching by FRET to an acceptor fluorophore has a
different distance dependence than by electron transfer to/from electron acceptor/donor residues.
This study aims at addressing the relative contribution of FRET compared to these other
quenching mechanisms. We found that that the near-vicinity of charged residues can affect the
quantum yield of a dye, which depends upon the charge of the dye, the charge on the residue, as
well as the distance between the two. In some measurements, the quantum yield of the dye will
not affect the results of the study; however when using a technique such as FRET, quantifying
the intensity of the dye in the environment that it is placed is very important. When using a
method such as donor-quenching FRET, the intensity of the donors dye is used to measure the
binding of the two partners, either protein-protein or protein-ligand. If the quantum yield (QY) of
the dye changes at any time in the experiment, then the results can show either an increase in
binding (for a decrease in QY) or a decrease in binding (increase in QY). We have developed a
system that allows for direct comparisons of parameters changed in order to determine the exact
effects of charges on fluorescent dye QY as well as how this changes apparent binding affinity.
4.3. Materials and Methods
4.3.1. Peptide Labeling
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Peptides with the sequence E15C, E6CE9 and K14CK were ordered from Genscript to
enable site-specific labeling using maleimide chemistry. E6CE9 was labeled with the donor dye
Alexa Fluor 488 (labeled polyE*). The E15C and K14CK were labeled with either a donor dye
or acceptor dye (labeled polyE and polyK). Labeling was carried out using a 5:1 ratio of dye to
peptide in 10 mM phosphate buffer at pH 7.2. The mixture of peptide and dye, protected from
light, were allowed to react overnight. The unreacted free dye was separated out by dialysis
using 2 kDa molecular weight cut-off dialysis tubing (Spectrum Labs). The samples were
dialyzed against 10 mM phosphate buffer for 24-48 hours with the external buffer being
refreshed every 2-6 hours. The samples were further cleaned up using 3 kDa spin columns
(Millipore). The labeling efficiency and separation of unreacted dye was verified by MALDI
mass spectrometry (Bruker Ultraflex II TOF/TOF time-of-flight mass spectrometer equipped
with a MALDI ion source) (BrukerDaltonik GmbH, Bremen, Germany).
4.3.2. Fluorescence Spectroscopy
Fluorescence measurements that were carried out in in the absence of an acceptor dye
were performed on a Perkin Elmer LS55. The concentration of labeled peptide was set at 1.0 ×
10-6 M. The unlabeled peptide concentration was 1.67 × 10-6 M to 1.65 × 10-8 M. The
fluorescence measurements that did include acceptor dyes were performed on a PTI
Quantamaster 40. The concentration of labeled polyE was set at 5.0 × 10-8 M. The concentration
of labeled polyK varied from 5 × 10-10 M to 1.5 × 10-6 M. For all experiments the sample was
excited at a wavelength depending upon the dye used (Table 4.1). Emission data was collected
10 nm from the excitation wavelength up to 750 nm. The transfer/quenching efficiency, E, was
calculated by using the relative fluorescence intensity of the donor at the maximum intensity in
the presence (FDA) and absence (FD) of the oppositely charge polypeptide17 using: E= 1 –
(FDA/FD). The KD value was calculated by fitting to the Hill18 equation in Origin.
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Table 4.1. Excitation and detection wavelengths as well as charges of dyes used.
Donor Dye
Excitation (nm)
Detection (nm)
Charge
Alexa 488

470

480-750

-1

Bodipy

470

480-750

0 (neutral)

Cy3

515

525-750

+1

Alexa 590

540

550-750

+/- (zwitterionic)

Alexa 568

580

580-750

-1

Atto 633

610

610-750

+1

4.4. Results and Discussion
We have investigated the FRET efficiency vs quenching by highly charged polypeptides
on attached fluorescent dyes. The magnitude of difference between the two mechanisms depends
greatly on the charge of the peptide, the charge of the dye, and the location of the dyes on the
peptide. When a fluorescent label was placed on a positively charged homopolypeptide, the
binding of a highly charged negative peptide significantly quenched the dye by 35-75%, figure
4.1. We believe this quenching is caused by the electrons being transferred from the excited
state of the fluorophore to the polyK peptide (figure 4.2) with an electron being transferred from
the polyE peptide back to the ground state of the fluorophore. This process is much more
efficient when the dye is placed on the polyK peptide vs placement on polyE. We believe this is
due to the distance that the excited electron has to travel in order to be transferred. The shorter
distance to the polyK means a quicker and more efficient transfer. When the dye is on the polyE,
it is farther away from the electron acceptor. In the case of the donor dye being in the middle of
the polyE chain, the fluorescence is quenched almost as efficiently as when the dye is attached
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directly on the polyK peptide. This drastic increase is likely due to the fact that there are now
multiple residues in the near vicinity of the dye to accept the excited electrons.
80

% of Fluorescence Quenched

70

60
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40

30

20

10

0
-1 *
-1
Alexa 488 Alexa 488

0
Bodipy

Dye Quenched by polyK

+1
Cy3

-1
Atto 633

+/+1
Alexa 590 Alexa 568

Dye Quenched by polyE

Figure 4.1. Percent of fluorescence quenched by charged peptides. On left side, the dye is
attached to polyE peptide and the addition of polyK decreases the signal. On the right side, the
dye is attached to the polyK peptide and the addition of polyE decreases the signal. The *
represents the polyE peptide where the cysteine is in the middle of the chain instead of at the
end.
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Figure 4.2.Schematic of peptide binding with relative quenching efficiency. A) The dye is
attached to the polyK peptide. An electron is easily transferred from the dye to the positively
charged peptide. PolyE gives up an electron in the ground state to the dye. B) The dye is attached
in the middle of the polyE peptide. The bound polyK takes an electron from the dye; the polyE
donates an electron back to the dye. Here the distance of travel is longer for the electron, but
there are multiple pathways. C) PolyE has the dye attached at the C-terminus. The polyK takes
an electron and the polyE donates one back. Here the distance is as long as in the middle
example, but there is only one possible peptide to except the charge.

Conjugating the Cy3 dye to the polyE peptide increases the quantum yield (figure 4.3) of
the dye by 2.4 times from 68% (free in solution) to 100%. This increase in brightness may be the
reason why the polyK does not appear to quench the dye, figure 4.1. In contrast, conjugation of
the dye to the polyK reduces the quantum yield from 68% to 42%. The change in quantum yields
are from the electron donating (polyE) or electron accepting (polyK) properties of the peptides
that the dyes are attached to. When there are an excess of electrons, the quantum yield increase
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to the maximum amount while the electron acceptor reduces the quantum yield by removing the
excited electrons before they have time to fully relax back to the ground state through the normal
fluorescence pathway.

100

80

QY %

60

40

20

0

Free Cy3

PolyK Cy3

PolyE Cy3

Figure 4.3.Quantum yield measurements for Cy3.The quantum yield of Cy3 was measured
for dye alone, dye attached to polyK, and dye attached to polyE.

The maximum transfer/quenching efficiency was examined to determine the relationship
between the energy transfer and electron transfer mechanisms, figure 4.4. In all cases studied, the
energy transfer results in a higher efficiency and greater reduction in donor fluorescence than
when the electron transfer quenching only is present, which is as expected when there are 2
processes occurring at the same time vs only a single quenching process. Since energy transfer
(FRET) occurs at longer distances with weaker distance dependence than the electron transfer of
standard quenching, it is not surprising that it gives a much larger signal change when comparing
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the unlabeled polyK to labeled polyK. In the case where the donor dye was placed in the middle
of the peptide instead of at the end, the energy transfer and electron transfer quenching both gave
very similar results with the electron transfer only being slightly more efficient. The energy
transfer in this situation is lower than when the dyes are both placed at the end because of the
longer distance between the two dyes. The electron transfer is higher than the other samples
where polyK is quenching the dye but lower than those where the polyE is the quencher (figure
4.2. We expect this is due to the peptide orienting itself in such a way that the dye is close to the
polyK peptide but not as close as it would be if the dye was conjugated to the peptide, figure 4.4.
In the bottom of figure 4.4, the energy transfer as well as electron transfer graphs are shown for
the Cy3 sample. The KD value is obtained by finding the midpoint of the curve. Both of these
curves have very similar midpoints suggesting the KD value is the same regardless of the method
used to measure binding.
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Transfer/Quneching Efficiency
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Figure 4.4. The maximum transfer/quenching efficiency is compared between labeled and
unlabeled samples sorted by charges. A) Labeled acceptor peptide in red, unlabeled acceptor
peptide in black. In all labeled cases, the acceptor is Atto 633.B) Transfer/Quenching curves are
shown for Cy3 with labeled acceptor (red) unlabeled acceptor (black).
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In figure 4.5, the measured binding constants are presented for each of the dye pairs depending
upon the charge and whether or not the acceptor peptide has a dye. The KD values for labeled vs
unlabeled polyK for each pair are equal or very close to equal for all pairs except when the -1
charged dye is placed at the end of the peptide chain. When the dye was in the middle of the
peptide the binding constant that was measured through energy transfer and electron transfer
were both very close (KD = 54 nM +/- 24 nM vs KD = 59 nM +-/ 24 nM, respectively) and
comparable to that of the control (measured using ITC where neither peptide is labeled, KD = 12
nM. When the +1 charged dye was used, the KD values for both labeled and unlabeled acceptor
peptide were very close to each other, KD = 348 nM +/- 13 nM vs 368 nM +/- 42 nM, but were
over an order of magnitude larger than the control, signifying a large effect from the donor dye.
When the neutral dye was used, the unlabeled sample measured a slightly higher KD value than
the labeled sample KD = 160 nM +/- 15 nM vs 90 nM +/- 6 nM, respectively. It would appear
that the neutral dye is somehow reducing the binding, either sterically or through electrostatics.
These results are all different from the -1 charged dye pair that show a tighter binding or lower
KD value when the acceptor dye is not present, KD = 67 nM +/- 10 nM vs 350 nM +/- 22 nM.
This increase in KD may come from the acceptor dye as well as the donor dyes being repelled
from their respective peptides and causing the peptides themselves to not be able to bind as they
would if the interfering dyes were not attached.
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Figure 4.5. Comparison of the measured binding coefficients based upon the charge of the
donor dye on polyE and whether or not the acceptor was labeled. Black: PolyK Peptide is
unlabeled; Red: PolyK peptide is labeled with acceptor dye. The * represents the polyE peptide
where the cysteine is in the middle of the chain instead of at the end.

4.5. Conclusions
Taking all of these results into consideration, it is clear that using fluorescent dyes around highly
charged residues can severely effect results when reporting the total degree of quenching, rather
than expanding on which quenching mechanism is responsible. In using FRET, it is common to
use the decrease in donor fluorescence to measure binding. We determined that the effects of the
charged environment on this parameter are unique to the dye as well as the environment. Each
dye charge exhibited different effects in the highly charged environment, although each one did
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give a similar KD value, with the exception of the -1 charged dye. The amount of quenching
through either FRET or electron transfer also varied by dye. It would appear as though the
acceptor dye may not always be important for the measurement of binding affinity with
fluorescence, as long as there is some sort of quencher available for the donor signal. In the case
that a donor and acceptor dye are required, the donor dye should not be placed in a highly
charged environment. If the options for dye placement are limited, then the best option is to use a
neutral dye or to label your molecules in a manner so that the fluorescent dyes only come close
enough to show high FRET but not close enough to interact. The distance needed will depend on
the Forster distance for your chosen dye pair. It would also be advisable to not place your
fluorescent label next to a charged amino acid since the quantum yield of the dye can be either
reduced or increased based upon the charge of the amino acid.
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V. Purification, Labeling, and FRET with FGFR and FGF

5.1. Abstract
Fibroblast growth factor receptor is involved in many important biological processes
across different species as well as various tissue types. When FGFR goes unregulated, the result
can be deadly. Almost all major cancers have a connection to unregulated FGFR. This protein is
thought to have a self-regulatory process that reduces the ability for the receptor to bind to FGF,
which is necessary for signaling. There are two competing models of self-regulation. We started
looking at ways to either prove or disprove the two models. Our preliminary results show that the
leading model in the literature may not be correct.
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5.2. Introduction
Fibroblast growth factors (FGF’s) are involved in numerous biological processes
including wound healing and development1-3. FGF’s activate the fibroblast growth factor
receptor (FGFR). There are more than 20 different FGF’s but only 4 FGFR’s4. These receptors
are found in several different tissue types and the amount of each depends on the tissue it is in.
FGFR participates in many different signaling processes5. The physical makeup contains 3
immunoglobulin-like domains (D1-3) as well as a transmembrane region and cytoplasmic
region6. All of the ligand binding occurs in the second (D2) and third (D3) domains with the D3
domain only playing a small role. There is a disordered region (D1) and a flexible region (acid
box, AB). The AB connects the first and second regions (figure 5.1). This flexible region is
termed the acid box because of the high percentage of acidic residues it contains. It is thought to
participate in an auto-inhibition mechanism that involves the acid box and the ligand binding
domain on D27, 8. When FGFR goes unregulated, there are a plethora of diseases that can be
obtained, including cancer9-11. FGFR must bind to both FGF and heparin in order for it to signal.
There are two models proposed for the elf-regulation or auto-inhibition of FGFR. The first model
predicts the AB will bind to the heparin binding site on the D2 domain7. This binding event is
assumed to block FGF from binding and therefore inhibits signaling. We have devised
experiments to determine if in fact the acid does bind to the D2 domain or if the other competing
model is true. The second model hypothesizes that the AB binds to FGF instead8. In this model,
when AB binds to FGF, the FGF binding site on D2 is blocked and keeps other FGF molecules
from binding. Through ITC and FRET both, we were only able to measure very little to no
binding between the acid box and the D2 domain of FGFR leading us to believe the secondary
model of auto-inhibition is more correct than the primary model.
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Figure 5.1. FGFR linear layout. FGFR contains 3 IG like domains (D1-3), an acid box region,
a transmembrane region, and 2 tyrosine kinase domains.

5.3. Materials and Methods
5.3.1. Acid Box Peptide
The acid box peptide was ordered from Genscript with the sequence of V-T-D-A-I-S-SG-D-D-E-D-D-T-D-G-A. This sequence aligns with residues 174 through 190 of FGFR212.
5.3.2. PCR, Expression, Purification of D2 and D2D3 domains of FGFR2 and FGF1
The D2, D2D3 domains of FGFR2 as well as FGF1 was mutated to include cysteines at
single locations using a QuikChange XL Site Directed Mutagenesis Kit from Stratagene. A histag was added to the N-terminal end of the D2D3 domain using the mutagenesis kit as well. All
primers used in PCR were ordered from IDT DNA Technologies. The thermocycler used for
PCR was a master cycler gradient. Overexpression of the D2, D2D3 domains as well as the
FGF1 protein was performed as previously reported by Hung13 using BL-21DE3 PLys cells
from E. coli (Novagen). After shaking at 37°C and 160 rpms until OD at 600 nm reached 0.6,
IPTG (Isopropylthio-β-D-galactoside, 0.5 mM/L) was added to induce growth. Shaking and heat
stayed constant until OD at 600 nm reached 1.5-2.0. The bacteria were then centrifuged at 6000
rpms for 20 minutes. The pellet was then resuspended in a buffer containing 1xPBS (pH=7.2),
1% v/v BME (β-mercaptoethanol), and 10 mM PMSF (phenylmethanesulfonylfloride). The cells
were then lysed using a sonicator in 1 sec pulses for 55 pulses. The sample was then centrifuged
again at 16,000 rpms for 20 minutes to remove cellular debris. For the D2, D2D3 proteins, the
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pellet is resuspended again in buffer containing 8 M urea and centrifuged at 10,000 rpms for 20
minutes. Purification of D2, D2D3 proteins was performed using a nickel affinity column
(Clontech), as described by Hung13. The protein was loaded onto the column after equilibration
with 8 M urea. The protein was eluted with a gradient of imidazole with urea (20 mM to 500 mM
imidazole, 8 M to 0 M urea). The D2, D2D3, and FGF proteins were also purified by heparin
affinity chromatography (GE Healthcare). The protein was loaded onto the column using a
buffer containing 10 mM phosphate, pH 7.2. The proteins were eluted using a gradient of NaCl,
from .2 M to 1.5 M. Purification was verified by SDS-PAGE (sodium dodecyl sulfate
polyacrylamide gel electrophoresis), figures 5.2-5.8. Figure 5.2 displays the gel after purification
by a heparin column. The protein of interest (D2 wild type) has a molecular weight of 14 kDa.
The band on the gel appears slightly below the molecular weight marker of 17 kDa. In Figure
5.3, the D2 mutant 236C was purified also on a heparin column. The band on this gel is also
slightly below the 17 kDa molecular weight marker. Figure 5.4 shows the gel after the
purification of D2D3 wild type. Here the weight of the protein is 24.8 kDa. The band appears
level with the 25 kDa marker. It should be noted that the molecular weight marker erroneously
showed a double band for 25 kDa. Figure 5.5, 5.6, and 5.7, are all from the purification of the
D2D3 protein. Each figure represents a different mutant however. For all cases, the band is
around the 25 kDa marker. In figure 5.8, the gel shown is from the purification of FGF wild type.
The molecular weight of this protein is 16 kDa and the band is present alongside the 17 kDa
marker.
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Figure 5.2. Gel of D2 wild type purification after the heparin column. The molecular weight
of D2 is ~14 kDa. The band is slightly below the 17 kDa marker.

Figure 5.3. Gel of D2 236C purification after the heparin column. Our protein is slightly
below the marker for the 17 kDa control, which is where it should be.

Figure 5.4. Gel of D2D3 wild type purification after the heparin column. The molecular
weight of D2D3 is 24.8 kDa. The molecular weight marker that was used erroneously showed a
double band at 25 kDa.
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Figure 5.5. Gel of D2D3 219/236C purification after the heparin column. The protein of
interest produced a band slightly below the 25 kDa molecular marker control band. Protein of
interest = 24.8 kDa.

Figure 5.6. Gel of D2D3 236/281C purification after the heparin column. Protein of interest
molecular weight is 24.8 kDa. Band is present below 25 kDa marker.

Figure 5.7. Gel of D2D3 222C purification after the heparin column. The molecular weight
marker that was used erroneously showed a double band at 25 kDa. The protein of interest’s
band was right above the 25 kDa molecular weight marker. Molecular weight of protein = 24.8
kDa.
90

Figure 5.8. Gel of FGF wild type purification after the heparin column. The molecular
weight of FGF is ~16 kDa. The band is almost even with the 17 kDa marker band.
5.3.3. Fluorescent Labeling of acid box, D2, D2/D3 and FGF
Acid box peptide was labeled with the donor dye Alexa Fluor 488. Labeling was carried
out using a 5:1 ratio of dye to peptide in 10 mM phosphate buffer at pH 7.2. The mixture of
peptide and dye, protected from light, were allowed to react overnight. The unreacted free dye
was separated out by dialysis using 2 kDa molecular weight cut-off dialysis tubing (Spectrum
Labs). The samples were dialyzed against 10 mM phosphate buffer for 24-48 hours with the
external buffer being refreshed every 2-6 hours. The labeling efficiency was verified by MALDI
mass spectrometry for the acid box; figure 5.9 (Bruker Ultraflex II TOF/TOF time-of-flight mass
spectrometer equipped with a MALDI ion source (Bruker Daltonik GmbH, Bremen, Germany)).
The proteins (D2, D2D3, FGF) were labeled using between 10:1 and 15:1 ratios of dye to protein
in 10 mM phosphate buffer at pH 7.2. Tris (2-carboxyethyl) phosphine (TCEP) was added to the
solution 30 minutes before the dye was introduced in order to reduce surface disulfide bonds.
The mixtures were allowed to sit for 2 hours after the addition of dye, at room temperature and
protected from light. The samples were then centrifuged in 3 kDa spin tubes (Millipore) to
remove all unbound dye. The absorbances of the samples were taken to determine amount of
labeling.
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Figure 5.9. MALDI results from acid box labeling with Alexa488. The molecular weight of
the acid box peptide is 1670.7 Da. The weight of the peptide + dye is 2368.7 Da. The peaks on
the right side of the major peak presents the sample with sodium ions attached.

5.3.5. Isothermal Calorimetry
All ITC data was collected on a Microcal VP titration calorimeter (Northhampton, MA,
USA). For D2 with acid box, the D2 concentration was 53 µM, the acid box was 499 µM. The
injection volume was 6 µL with 30 injections. The buffer was 10 mM Phosphate, pH=7.2. The
data was fit using Origin and the χ2 value was used to determine the best fit.
5.3.6. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy
FRET measurements were made on a PTI Quantamaster 40. The concentration of labeled
acid box was set at 5.0 × 10-8 M. The concentration of labeled FGF varied from 5.0 × 10-10 M to
1.5 × 10-6 M. For D2 or D2D3 with FGF, the D2 (or D2D3) sample had the same concentration
as the acid box (above) and the FGF remained the same as listed above. The sample was excited
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at 470 nm and emission data was collected from 480 nm to 750 nm. The transfer efficiency was
calculated by using the relative fluorescence intensity of the donor at 516 nm in the presence
(FDA) and absence (FD) of the acceptor14 using: E= 1 – (FDA/FD). The KD value was calculated by
fitting to the Hill equation in Origin.15
5.4. Results
In order to measure the binding of the FGFR with FGF using FRET, we had to add a
cysteine into the sequence of the protein to add a fluorescent label. The un-changed sequences
for D2, D2D3, and FGF are shown in figures 5.10-5.12, respectively. By using site directed
mutagenesis, we were able to make a mutation at amino acid 236 for D2. Some of the mutations
that we tried to make but never could get to work were: 155C, 219C, and 281C. For the D2D3
construct, the mutations that worked were: 219/236C (double), 236/281 (double), 222C, 241C,
and 356C. The mutations that did not work were: 265C, 267C, 308C, 309C, and 358C. For FGF,
the mutations that worked were 2C and 49C. After the mutations were made, some of the
samples could not be purified to a high degree. These were samples D2D3 241C and D2D3
356C. After receiving the sequence for the D2D3 protein, it was discovered that there was not a
His-tag on the protein. We performed PCR in order to add a His-tag. The amino acid sequence
for the D2D3 domains after the addition of the His-tag is shown in figure 5.13.

Met N S N N K R A P Y W T N T E K M E K R L H A V P A A N T V K F R C P A G G N P
MPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDK
G N Y T C V V E N E Y G S I N H T Y H L D V V L E H H H H H H Stop
Figure 5.10. Primary sequence for D2. This is the wild type sequence of D2. The his-tag is at
the C-terminus of the protein.
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Met N S N N K R A P Y W T N T E K M E K R L H A V P A A N T V K F R C P A G G N P
MPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDK
GNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANAST
VVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYL
KVLKHSGINSSNAEVLALFNVTEADAGEYICKVSNYIGQANQ
S A W L T V L P K Q Q A P G R E Stop
Figure 5.11. Primary sequence for D2D3. This is the original sequence for the D2D3 protein.
Notice the lack of a his-tag. Without this tag, we could not purify the protein using affinity
chromatography.

Met F N L P P G N Y K K P K L L Y C S N G G H F L R I L P D G T V D G T R D R S D Q
HIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEE
CLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTH
Y G Q K A I L F L P L P V S S D Stop
Figure 5.12. Primary sequence for FGF. This sequence is the wild type sequence for FGF. We
were able to purify FGF by using a heparin column alone, without the need to include a nickel
column.

Met N S N N K R A P Y W T N T E K M E K R L H A V P A A N T V K F R C P A G G N P
MPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDK
GNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANAST
VVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYL
KVLKHSGINSSNAEVLALFNVTEADAGEYICKVSNYIGQANQ
S A W L T V L P K Q Q A P G R E H H H H H H Stop
Figure 5.13. Sequence for D2D3 after addition of His-tag. This is sequence of the D2D3 after
the addition of a his-tag at the C-terminus. This sequence will be referred to as the wild type
D2D3.

Labeling the mutants that we made proved to be difficult. Before labeling, the absorbance
of every protein was measured in order to determine the concentration, figure 5.14. After
labeling, the samples were sent to the Arkansas Statewide Mass Spectrometry Facility for
analysis. Figure 5.15 an example of the MALDI results after labeling. This MALDI spectrum
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shows that we had protein with several variations of numbers of dyes attached. Since the
maximum that we could have had with the protein folded was 1, the rest are indicative of
unfolded protein, which we also saw with the absorbance measurement in figure 5.16. We
successfully labeled D2 236C with Alexa488, figure 5.17, even though a small amount of the
sample did appear to have 2 dyes attached. When we were trying to label the D2D3 double
mutants, we would add both of the dyes in at the same time. It did not matter where either of the
dyes attached, only that both dyes were on each molecule. Several times we would end up with
aggregated samples, figure 5.18. Other times we would have samples that only had a single dye
attached, figure 5.19. We decided to start attaching one dye then the other, but this too yielded
poor results. We obtained samples that had a low labeling efficiency; figure 5.20 for example,
had a 5:1 ratio of protein of dye.
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Figure 5.14. Spectra of D2 236C before labeling. The peak at 280 nm signifies the presence of
protein that is not aggregated.
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Figure 5.15. MALDI results from D2 236C with Alexa488. The peak at 13150 represents the
protein. All of the peaks with a higher M/Z ratio represent the protein with dye, +2 dye, +3 dye
and so forth. Here the extra dye that are attached come from the protein most likely being
unfolded so the native cysteines were available for labeling.
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Figure 5.16. Spectra of D2 236C after labeling with Alexa488. The peak at ~500 nm is from
the dye, Alexa 488. The large peak that does not come back down indicates aggregated protein.
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Figure 5.17. D2 236C with Alexa488. The peak at 13216 indicates the protein. The next
downfield peak is for protein + dye, the last labeled peak is for protein +2 dyes. The extra dye is
likely a result of unfolding of the protein, allowing the normally buried native cysteines to be
available to accept the dye.
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Figure 5.18. Absorbance of D2D3 219/236C. The sample contains both of the dyes, but it also
appears to be aggregated by the peak that starts at 285 nm and does not come back down.
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Figure 5.19. Absorbance of D2D3 236/281C. The sample contains one of the dyes, but not the
other. Tt also appears to be aggregated by the peak that starts at 400 nm and does not come back
down. The overall concentration of the dye is very low, ~1x10-7 M.
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Figure 5.20. D2D3 236/281C with Cy3. The peak at ~550 nm donates the presence of Cy3
while the peak at 280 nm indicates the presence of protein.

The wild type FGF has 3 native cysteines. We determined that none of these cysteines
were available for labeling by adding dye to the protein and then purifying the sample. In every
case, the ratio of protein to dye was very high, anywhere from 37:1 to 20:1, figure 5.21. Because
of this, we decided to introduce a cysteine at position 49. This mutant was successful and was
easily purified. The labeling was also somewhat successful with a 7:1 ratio of protein to dye.
This sample was not, however, refolded properly. After labeling, the sample was aggregated
(figure 5.22). After the aggregates were dissolved, the protein would not bind to the D2D3
protein, figure 5.23.
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Figure 5.21. Absorbance spectrum of FGF with Cy5 dye. The peak at ~650 nm is from the
Cy5 dye while the peak at 280 nm is from protein.
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Figure 5.22. Absorbance spectrum of FGF-49C with Alexa488. The presence of Alexa 488 is
denoted by the peak at 500 nm while the lack of a defined peak at 280 nm suggests aggregated
protein.
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Figure 5.23. Ensemble FRET with FGF and FGFR. The scattered data points suggest no
binding between the receptor and FGF.

In our ITC experiments, D2 wild type was titrated with the acid box peptide. This
experiment showed very weak to no binding, figure 5.24. We performed the same experiment
using FRET to determine if the two were binding on a small scale. FRET also showed no
binding, figure 5.25. We also decided to try ITC with the D2 wild type with a polypeptide that
was designed to mimic the acid box peptide, but only contained glutamic acid. This peptide is
termed PolyE and contains 15 amino acids, E15. For this experiment, there was binding between
the protein and peptide even though it was weak (37 mM), figure 5.26.
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Figure 5.24. ITC of D2 wild type with acid box peptide. The ITC results indicate that only a
very small amount of binding took place between the acid box peptide and the D2 domain.
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Figure 5.25. FRET of D2 236C with acid box peptide. Green and purple represent two
different trials. There was extremely weak binding in both. Data could not be fit to model
because of extremely weak binding between the acid box peptide and the D2 domain.
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Figure 5.26. ITC of D2 wild type with PolyE peptide. ITC confirms that the polyE peptide
does bind to the D2 domain, with relatively weak binding, KD = 37 mM.

5.5. Discussion and Conclusion
The auto-inhibition of FGFR is thought to occur by the acid box region of the receptor binding to
the heparin binding site of the receptor16. In this model, the acid box binding on the heparin
binding site is supposed to block heparin and the FGF from binding to the receptor7. Even
though this is a popular model in the literature7, 16, our results from ITC (figure XX) as well as
FRET (figure XX) both show little to no binding between the acid box and FGFR. Our results
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are preliminary and we hope future results will help to clear up the questions left at this point.
Our results do however, correlate with Rutherford et al. who saw that the acid box has a higher
affinity for FGF than for the receptor8.
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VI. Conclusion
This body of work was aimed at determining if the auto-inhibition mechanism for FGFR that is
popular in the literature is acruate1. This work was started by making a simplified homopolypeptide that
would eventually morph into the actual amino acid sequence proposed to be involved in auto inhibition
by FGFR. One model peptide was made to mimic the acid box – a 15-mer of glutamic acid (polyE). In the
actual protein, the binding site on FGFR was thought to be a positively charged region in the D2 domain
that binds to heparin. We used a 15-mer of polylysine (polyK) to mimic this binding site. For the
polypepides that were used in FRET studies, a cysteine residue was added to enable site-specific labeling
using maleimide-functionalized dyes that react specifically with the terminal –SH group on cysteine. The
binding of the peptides were characterized by ITC, CD, FRET, and NMR (chapter 2) and it was
discovered that they bind in a parallel arrangement almost exclusively via long-range electrostatic
interactions of the side-groups with little-to-no involvement of backbone hydrogen bonds. This leads to
the polypeptides to remain as random coils after interacting. A parallel arrangement and electrostatic only
interactions are somewhat counterintuitive, since longer versions of these peptides have been shown to
form beta-sheets after interacting. Our data clearly shows that polypeptides of this length do not form
beta-sheets in aqueous solution until the solvent polarity is decreased by adding trifluoroethanol. A recent
molecular dynamics study2 showed that for 5-mers of polyE and polyK in dried layers, the difference in
energy between parallel and anti-parallel arrangements was rather small, with the parallel arrangement
resulting in more compact sheets. It is possible that, when the solvent is included and the length of the
polypeptides is increased, such as in our studies, the balance of entropy and enthalpy shifts towards
maintain a more entropically-favored random coil. In fact, our ITC results showed that both the DS and
the DH of interaction is positive at neutral pH in both lower and higher ionic strength condition, verifying
that the interaction is largely entropically driven. In the MD study2 a parallel arrangement was shown to
result in a larger distance between the peptides, which may allow the solvent to interact with the charged
side groups enough to increase the entropy enough to balance out the enthalpy that would be gained by
forming hydrogen bonds that leads to the formation of beta sheets. The question remains as to the
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minimum length and charge composition of peptide that is needed to maintain this entropy balance before
the formation of intra-peptide hydrogen bonds shifts the balance towards the formation of secondary
structure. Indeed, answering such a question may prove to be extremely important in the area of amyloid
formation that involve IDPs coming together to form ordered structures (often beta sheets) that have been
implicated in several diseases such as Alzheimer’s3, Parkinson’s4, Cystic Fibrosis and the human
equivalent of Bovine Spongiform Encephalopathy (BSE), Creutzfeldt-Jakob disease (CJD)4.
Through the course of the FRET studies with the polypeptides, we noticed that the exact
quantification of our FRET data seemed to depend on the choice of dyes used. This forced us to start
examining the role that fluorescent dyes played in the interaction of the charged polypeptides that we
were using. In chapters 3 and 4, we were able to quantify the effects of the charges on the dyes
themselves, as well as the effect of the charged amino acids on the dye fluorescence – both of which are
very important for correct interpretation of FRET data. In chapter 3, we elucidated the fact that bulky,
rigid dyes inhibited peptide binding and reduced the binding affinity but also decreased the cooperativity
of binding, as evidenced by the change in the Hill coefficient extracted from our fits. Furthermore, dyes
that had the same charges also reduced the KD value since they repelled each other, keeping the peptides
apart. The structural flexibility of the dye also plays a major role, since this allows the dye to adopt
conformations that interact less with other dyes. These effects are amplified when the dyes are forced into
close proximity of each other, which was allowed in our system by the strong preference of the
polypeptides to bind in a parallel arrangement. One important question to answer would be what the
minimum distance is that the dyes must be placed apart from each other for them to have a negligible
effect on the data. It is anticipated that, at larger distances, the charge of the dyes would become more
important that their bulkiness and rigidity, since charge-charge interactions are longer range than the
dimensions of the dye. Answering such questions is important when designing FRET assays to look at
protein interactions, especially those involving electrostatic interactions. The results of chapter 3 have

110

gone a long way towards this goal, since it shows which dye combinations work better than others when
dyes must be placed relatively close together.
Since our peptides were so highly charged, it was also necessary to uncover the effect of these
charges on the quantum yield of our dyes when attached to, or brought into close proximity to, such
residues (chapter 4). How the quantum yield of the dyes is affected by these highly-charged environments
are very important to accurately measure FRET efficiencies which are used to extract inter-fluorophore
separation and, in turn, structural information about the labeled biomolecules. After determining that the
dye quantum yield was in fact influenced by the amino acid chain it was attached to, we monitored the
change in quantum yield after the peptides bind to each other. We were able to establish a general
mechanism for the quenching of the fluorescence of our dyes. This mechanism involves the transfer of an
electron from the dye to the polyK peptide, which depends strongly on the distance between the dye and
the amino acid chain as well as the number of quenching pathways (number of lysine residues) available
within the short quenching distance. Since this quenching competes with FRET, lacking such knowledge
of quenching will overestimate the FRET efficiency and may lead to inaccurate conclusions to be drawn
regarding the structural details uncovered by FRET. The results of chapter 4 will help to correctly
interpret FRET results when dyes are placed into close proximity of charged amino acids to enable more
accurate inter-fluorophore distances to be extracted.
Once we had quantified the how interacting charged residues affected each other’s structure and
the roles that attached dyes played on this interaction, we then moved on to studying the more complex
FGFR system. After the addition of a hexahistidine tag to the obtained FGFR plasmid through PCR
(chapter 5), we were able obtain purified protein. FGFR contains 2 cysteines per domain (D2 and D3), but
these residues are not available for labeling since they form disulfide bridges after folding. Because of
this, we decided to add a cysteine into the sequence at various points in order to have several protein
labeling options. Each mutation was made for a single protein variant, some containing single cysteines to
enable inter-molecular FRET between FGFR and its binding partner and some containing double
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mutations to enable intra-molecular FRET to be performed on FGFR. The single mutations enabled
binding between FGFR and FGF or FGFR and the acid box peptide to be measured by FRET. After initial
studies with ITC and FRET, the expected binding between FGFR and the acid box could not be verified,
bringing into question one of the proposed mechanisms for FGFR auto-regulation1. Unfortunately, we
have not been able to measure binding between FGFR and FGF, which is another proposed mechanism of
FGFR autoregulation, due to the FGF being unstable after labeling and aggregation issues.
Since one the proposed autoregulation mechanisms have been brought into doubt, future work
should investigate alternative mechanisms. Such a project will include the following steps: 1) Producing
new mutants of FGF that could potentially be more stable. After obtaining stable FGF, FRET and even
single molecule FRET could be performed between FGFR and FGF. These studies should be able to
determine if the acid box binds to FGF to determine if the alternative FGFR autoregulation mechanism is
viable. If the binding between FGF and the acid box is present, NMR studies can also be conducted to
determine where the binding is taking place on FGF. 2) The binding between FGF and the acid box
should also be measured in the presence and absence of the D2D3 regions. This study will help to
uncover whether the binding of FGF to the acid box is preferred over D2D3 or if this interaction is only a
side effect. Just because the acid box will bind, does not mean that it is going to bind when other potential
partners are available. 3) Measure the binding of peptides with all of the different FGFR acid box
sequences since each receptor has a slightly different one. FGFR1 is the highest regulated with the longest
acid box. The binding of these acid boxes could be compared to the regulation level for each one, after the
binding mechanism is determined. 4) Determine the minimum number of charged amino acids that are
required for the acid box to bind to its partner (either FGF or FGFR). It could be very helpful with future
binding mechanisms if the minimal amount of charged residues is known. 5) Expand the
homopolypeptide study by changing the amino acids one at a time to glycine and then measuring the
binding between the polyE and polyK. Since there are many intrinsically disordered proteins in the body,
these polypeptide systems could be changed to mimic some of those systems more closely. By changing
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one amino acid at a time, we could determine if small changes could force folding changes, aggregation,
or even binding changes that we could not foresee.

113

6.1 References
1.

2.
3.
4.

Kalinina, J., Dutta, K., Ilghari, D., Beenken, A., Goetz, R., Eliseenkova, Anna V., Cowburn, D., and
Mohammadi, M. (2012) The Alternatively Spliced Acid Box Region Plays a Key Role in FGF
Receptor Autoinhibition, Structure 20, 77-88.
Zhao, W., Zheng, B., and Haynie, D. T. (2006) A Molecular Dynamics Study of the Physical Basis
of Stability of Polypeptide Multilayer Nanofilms, Langmuir 22, 6668-6675.
Savelieff, M. G., Lee, S., Liu, Y., and Lim, M. H. (2013) Untangling amyloid-β, tau, and metals in
alzheimer's Disease, ACS Chem. Biol. 8, 856-865.
Norrby, E. (2011) Prions and protein-folding diseases, J. Intern. Med. 270, 1-14.

114

